Publications and communications of Vincenzo Castronovo

Paul, C., Tang, R., Longobardi, C., Lattanzio, R., Eguether, T., Turali, H., Bremond, J., Maurizy, C., Gabola, M., Poupeau, S., Turtoi, A., Denicolai, E., Cufaro, M. C., Svrcek, M., Seksik, P., Castronovo, V., Delvenne, P., de Laurenzi, V., Da Costa, Q., ... Hahne, M. (06 December 2022). Loss of primary cilia promotes inflammation and carcinogenesis. EMBO Reports, 23 (12), 55687. doi:10.15252/embr.202255687

Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim Meriem, Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (September 2022). Immunosuppressive effect of methylglyoxal stress in breast cancer [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Belgium.

Rademaker, G.* , Boumahd, Y.* , Peiffer, R., Anania, S., Wissocq, T., Liégeois, M., Luis, G., Sounni, N. E., Agirman, F., Maloujahmoum, N., De Tullio, P., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (July 2022). Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Redox Biology, 53, 102324. doi:10.1016/j.redox.2022.102324
* These authors have contributed equally to this work.

Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim, M., Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (21 June 2022). Methylglyoxal reshapes breast tumor immune microenvironment [Poster presentation]. European association for cancer research congress 2022, Séville, Spain.

Mohring, V., Wissocq, T., Hubert, P., Herfs, M., Tiamiou, A., Hasmim Meriem, Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (2022). Methylglyoxal regulates the recruitment of tumor-infiltrating immunosuppressive cells in breast cancer [Poster presentation]. PhD Day UNamur 2022, Belgium.

Rademaker, G., Costanza, B., Pyr Dit Ruys, S., Peiffer, R., Agirman, F., Maloujahmoum, N., Vertommen, D., Turtoi, A., Bellahcene, A., Castronovo, V.* , & Peulen, O.*. (2022). Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination. Oncogenesis, 11, 42. doi:10.1038/s41389-022-00416-4
* These authors have contributed equally to this work.

Tiamiou, A., Dube, G., Bizet, M., Bellier, J., Deplus, R., Nokin, M.-J., Wissocq, T., Gasmi, I., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (09 June 2021). Methylglyoxal Induces An Epigenetic Deregulation leading to the Silencing of Tumor-Suppressor Genes in Breast Cancer [Poster presentation]. EACR Congress, Innovative Cancer Science, Better Outcomes through Resarch.

Wissocq, T., Hubert, P., Tiamiou, A., Hasmim, M., Nokin, M.-J., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (May 2021). Methylglyoxal, a byproduct of glycolysis, modulates breast cancer immune landscape [Poster presentation]. 4th METABOLISM & CANCER SYMPOSIUM VIRTUAL MEETING, Bordeaux, France.

Chiavarina, B., Costanza, B., Ronca, R., Blomme, A., Rezzola, S., Chiodelli, P., Giguelay, A., Belthier, G., Doumont, G., Van Simaeys, G., Lacroix, S., Yokobori, T., Erkhem-Ochir, B., Balaguer, P., Cavailles, V., Fabbrizio, E., Di Valentin, E., Gofflot, S., Detry, O., ... Turtoi, A. (January 2021). Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis. Theranostics, 11 (4), 1626-1640. doi:10.7150/thno.51507

Anania, S., Peiffer, R., Rademaker, G., Hego, A., Thiry, M., Deldicque, L., Francaux, M., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (21 June 2020). Myoferlin is a yet unknown interactor of the mitochondrial dynamics’ machinery in pancreas cancer cells. Cancers, 12 (6), 1643. doi:10.3390/cancers12061643

Hoge, A., NISOLLE, M., Castronovo, V., & Guillaume, M. (June 2020). Importance de la consommation d’acides gras polyinsaturés oméga-3 pendant la grossesse: différences de perception entre les femmes enceintes et les gynécologues-obstétriciens. Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 25 (4).

Hoge, A., Donneau, A.-F., Dardenne, N., Nisolle, M., Guillaume, M., & Castronovo, V. (May 2020). Pertinence des acides gras polyinsaturés oméga-3 érythrocytaires en début de grossesse comme indicateur de l’état de santé maternelle, foetale et néonatale. Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 25 (3).

Hoge, A., Nisolle, M., Guillaume, M., & Castronovo, V. (April 2020). Importance des acides gras polyinsaturés oméga-3 durant la grossesse: mode ou réalité scientifique? Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 25 (2).

Tiamiou, A., Dube, G., Bizet, M., Bellier, J., Deplus, R., Wissocq, T., Gasmi, I., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (07 February 2020). Dicarbonyl stress induces an epigenetic deregulation leading to a pro-migratory phenotype in breast cancer [Poster presentation]. Belgium Assocication for Cancer Research (BACR), Bruxelles, Belgium.

Wissocq, T., Hubert, P., Caprasse, M., Nokin, M.-J., Noman, M. Z., Peulen, O., Castronovo, V., Janji, B., & Bellahcene, A. (07 February 2020). Methylglyoxal stress contributes to immunosuppression in breast cancer [Poster presentation]. Association Belge pour l'Etude du Cancer "A.B.E.C", Bruxelles, Belgium.

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012

Anania, S., Rademaker, G., Peiffer, R., Hego, A., Deldicque, L., Maloujahmoum, N., Agirman, F., Bellahcene, A., Castronovo, V., & Peulen, O. (February 2020). Role of myoferlin in mitochondrial dynamics and metabolic fitness of pancreas cancer [Poster presentation]. BACR Annual Meeting 2020 - Cancer metastases: from bedside to bench, Brussels, Belgium.

Hoge, A., Donneau, A.-F., Dardenne, N., Degée, S., TIMMERMANS, M., NISOLLE, M., Guillaume, M., & Castronovo, V. (2020). Impact of erythrocyte long-chain omega-3 polyunsaturated fatty acid levels in early pregnancy on birth outcomes: findings from a Belgian cohort study. Journal of Perinatology. doi:10.1038/s41372-019-0573-9

Anania, S., Rademaker, G., Bellahcene, A., Castronovo, V., & Peulen, O. (December 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of Pancreatic Ductal Adenocarcinoma [Poster presentation]. Second CIRM Scientific Day, Liège, Belgium.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (December 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic cancer cells by enhancing the migratory capacity through the control of oxidative phosphorylation [Poster presentation]. Cirm Annual meeting.

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (26 November 2019). Myoferlin depletion induces DNA damage response and p53- dependent cell cycle arrest and apoptosis in colon cancer [Poster presentation]. Metabolism in Cancer and Stromal Cells (2nd edition), Leuven, Belgium.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (November 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic cancer cells by enhancing the migratory capacity through the control of oxidative phosphorylation [Poster presentation]. Bioforum Uliège.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (23 October 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity Through the Control of Oxidative Phosphorylation [Poster presentation]. Pancreatic Cancer Symposium, Toulouse, France.

Anania, S., Rademaker, G., Wissocq, T., Bellahcene, A., Castronovo, V., & Peulen, O. (October 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of PDAC [Poster presentation]. PANCREATIC CANCER SYMPOSIUM, Toulouse, France.

Costanza, B., Rademaker, G., Turtoi, A., Bellahcene, A., Castronovo, V., & Peulen, O. (October 2019). TGFBI, an ECM interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration [Poster presentation]. Pancreatic Cancer Symposium 2019, Toulouse, France.

Anania, S., Rademaker, G., Wissocq, T., Bellahcene, A., Castronovo, V., & Peulen, O. (06 September 2019). Role of myoferlin in mitochondrial dynamics and metabolic fitness of pancreas cancer [Poster presentation]. EDT Cancerology 2019, Bruxelles, Belgium.

Peulen, O., Rademaker, G., Anania, S., Turtoi, A., Bellahcene, A., & Castronovo, V. (August 2019). Ferlin overview: from membrane to cancer biology. Cells, 8, 954. doi:10.3390/cells8090954

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (13 June 2019). Myoferlin Contributes to the Metastatic Phenotype of Pancreatic Cancer Cells by Enhancing Their Migratory Capacity Through the Control of Oxidative Phosphorylation [Poster presentation]. Belgian Society for Cell and Developmental Biology - Spring Meeting, Liège, Belgium.

Tiamiou, A., Dube, G., Bizet, M., Bellier, J., Deplus, R., Caprasse, M., Peulen, O., Castronovo, V., Fuks, F., & Bellahcene, A. (13 June 2019). A novel link between dicarbonyl stress and epigenetic regulation in breast cancer [Poster presentation]. Belgian Society for Cell and Developmental Biology (BSCDB), Liège, Belgium.

Rademaker, G., Costanza, B., Anania, S., Agirman, F., Maloujahmoum, N., Di Valentin, E., Goval, J.-J., Bellahcene, A., Castronovo, V., & Peulen, O. (June 2019). Myoferlin contributes to the metastatic phenotype of pancreatic cancer cells by enhancing their migratory capacity through the control of oxidative phosphorylation. Cancers, 11 (6). doi:10.3390/cancers11060853

Hoge, A., Tabar, V., Donneau, A.-F., Dardenne, N., Degée, S., TIMMERMANS, M., Nisolle, M., Guillaume, M., & Castronovo, V. (2019). Imbalance between Omega-6 and Omega-3 Polyunsaturated Fatty Acids in Early Pregnancy Is Predictive of Postpartum Depression in a Belgian Cohort. Nutrients. doi:10.3390/nu11040876

Castronovo, V., & Emmerechts, C. (14 March 2019). Non-destructive sampling device for extraction of a marker.

Costanza, B., Rademaker, G., Tiamiou, A., De Tullio, P., Leenders, J., Blomme, A., Bellier, J., Bianchi, E., Turtoi, A., Delvenne, P., Bellahcene, A., Peulen, O.* , & Castronovo, V.*. (2019). TGFBI, an ECM interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. International Journal of Cancer. doi:10.1002/ijc.32247
* These authors have contributed equally to this work.

Hoge, A., Bernardy, F., Donneau, A.-F., Dardenne, N., Degée, S., Nisolle, M., Guillaume, M., & Castronovo, V. (2019). Importance of n-3 PUFA consumption during pregnancy: perception discrepancies between pregnant women and gynaecologists–obstetricians in Belgium. Public Health Nutrition. doi:10.1017/S1368980019000089

Bellier, J., Nokin, M.-J., Lardé, E., Karoyan, P., Peulen, O., Castronovo, V., & Bellahcene, A. (2019). Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer. Diabetes Research and Clinical Practice. doi:10.1016/j.diabres.2019.01.002

Biver, E., Berenbaum, F., Valdes, A. M., Araujo de Carvalho, I., Bindels, L. B., Brandi, M. L., Calder, P. C., Castronovo, V., Cavalier, E., Cherubini, A., Cooper, C., Dennison, E., Franceschi, C., Fuggle, N., Laslop, A., Miossec, P., Thomas, T., Tuzun, S., Veronese, N., ... Rizzoli, R. (2019). Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Ageing Research Reviews, 55. doi:10.1016/j.arr.2019.100946

Hoge, A., Bernardy, F., Donneau, A.-F., Dardenne, N., Degée, S., NISOLLE, M., Guillaume, M., & Castronovo, V. (2019). Knowledge, attitudes and practices of pregnant women and gynecologists-obstetricians regarding omega-3 polyunsaturated fatty acid consumption during pregnancy. Archives of Public Health, 77(suppl 1).

Hoge, A., Tabart, V., Donneau, A.-F., Dardenne, N., Degée, S., TIMMERMANS, M., NISOLLE, M., Guillaume, M., & Castronovo, V. (2019). Un faible statut en acides gras oméga-3 à longue chaine en début de grossesse est associé à un risque plus élevé de dépression post-partum. Nutrition Clinique et Metabolisme, 33. doi:10.1016/j.nupar.2019.01.270

Medfai, H., Khalil, A., Rousseau, A., Nuyens, V., Paumann-Page, M., Sevcnikar, B., Furtmüller, P., Obinger, C., Moguilevsky, N., Peulen, O., Herfs, M., Castronovo, V., Amri, M., Van Antwerpen, P., Vanhamme, L., & Zouaoui Boudjeltia, K. (2019). Human peroxidasin 1 promotes angiogenesis through ERK1/2, Akt and FAK pathways. Cardiovascular Research, 115(2), 463-475. doi:10.1093/cvr/cvy179

Nokin, M.-J., Bellier, J., Durieux, F., Peulen, O., Rademaker, G., Gabriel, M., Monseur, C., CHARLOTEAUX, B., Verbeke, L., van Laere, S., RONCARATI, P., Herfs, M., Lambert, C., Scheijen, J., Schalkwijk, C., Colige, A., Caers, J., Delvenne, P., Turtoi, A., ... Bellahcene, A. (2019). Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Breast Cancer Research, 21(1, 11. doi:10.1186/s13058-018-1095-7

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (2019). Human colon cancer overexpress myoferlin to maintain a fit mitochondrial network and escape p53 dependent apoptosis [Poster presentation]. Belgian Association for Cancer Research Congress, Anvers, Belgium.

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Peiffer, R., Agirman, F., Maloujahmoum, N., Habraken, Y., Delvenne, P., Bellahcene, A., Castronovo, V.* , & Peulen, O.*. (2019). Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis. Oncogenesis. doi:10.1038/s41389-019-0130-6
* These authors have contributed equally to this work.

Hoge, A., Bernardy, F., Donneau, A.-F., Dardenne, N., Degée, S., TIMMERMANS, M., Nisolle, M., Guillaume, M., & Castronovo, V. (December 2018). L’analyse des acides gras érythrocytaires maternels en début de grossesse révèle un faible index oméga-3. Nutrition Clinique et Metabolisme, 32 (4). doi:10.1016/j.nupar.2018.09.215

Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journe, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (26 November 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. Metabolism in cancer and Stromal Cells, Louvain, Belgium.

Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journé, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (28 September 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. 3rd symposium of ULB - Cancer Research Center (U-CRC), Bruxelles, Belgium.

Tiamiou, A., Durieux, F., Nokin, M.-J., Bellier, J., Ghanem, G., Journé, F., Arrese, E. J., Bellahcene, A., & Castronovo, V. (13 September 2018). Methylglyoxal-induced cardonyl stress in melanoma progression and response to therapy [Poster presentation]. GIGA-Cancer Day 2018/EDT Cancerology, Liège, Belgium.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Herfs, M., Thiry, M., Bellahcene, A., Castronovo, V., & Peulen, O. (01 July 2018). Myoferlin controls mitochondrial structure and metabolism in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. EACR 25 50 Years, Amsterdam, Netherlands.

Bellier, J., Nokin, M.-J., Durieux, F., Journe, F., Ghanem, G., Castronovo, V., & Bellahcene, A. (30 June 2018). Methylglyoxal-induced Dicarbonyl Stress: Role in Melanoma Progression and Response to Therapy [Poster presentation]. Bellier, Amsterdam, Netherlands.

Brohée, L., Peulen, O., Nusgens, B., Castronovo, V., Thiry, M., Colige, A., & Deroanne, C. (04 May 2018). Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression. Scientific Reports, 8 (1), 7050. doi:10.1038/s41598-018-25340-9

Hoge, A., Bernardy, F., Donneau, A.-F., Dardenne, N., Degée, S., TIMMERMANS, M., Nisolle, M., Guillaume, M., & Castronovo, V. (April 2018). Low omega-3 index values and monounsaturated fatty acid levels in early pregnancy: an analysis of maternal erythrocytes fatty acids. Lipids in Health and Disease, 17, 63. doi:10.1186/s12944-018-0716-6

Rademaker, G., Hennequière, V., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (April 2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene, 37 ((32)), 4398-4412. doi:10.1038/s41388-018-0287-z

Blomme, A., van Simaeys, G., Doumont, G., Costanza, B., Bellier, J., Otaka, Y., Sherer, F., LOVINFOSSE, P., Boutry, S., Palacios, A. P., De Pauw, E., Hirano, T., Yokobori, T., Hustinx, R., Bellahcene, A., Delvenne, P., DETRY, O., Goldman, S., Nishiyama, M., ... Turtoi, A. (March 2018). Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases. Oncogene, 37 (9), 1237-1250. doi:10.1038/s41388-017-0018-x

Bellier, J., Nokin, M.-J., Durieux, F., Peulen, O., Koji, U., Spiegel A, Cochrane R, Hutton A, C., Castronovo, V., & Bellahcene, A. (27 January 2018). Hormetic potential of Methylglyoxal in switching cancer cells from growth to death [Poster presentation]. Bellier, Liège, Belgium.

Bellahcene, A., Nokin, M.-J., Castronovo, V., & Schalkwijk, C. (2018). Methylglyoxal-derived stress: an emerging biological factor involved in the onset and progression of cancer. Seminars in Cancer Biology. doi:10.1016/j.semcancer.2017.05.010

Costanza, B., Turtoi, A., Bellahcene, A., Hirano, T., Peulen, O., Blomme, A., Hennequiere, J., MUTIJIMA NZARAMBA, E., Boniver, J., Meuwis, M.-A., JOSSE, C., KOOPMANSCH, B., SEGERS, K., Yokobori, T., Fahmy, K., Thiry, M., COIMBRA MARQUES, C., Garbacki, N., Colige, A., ... Castronovo, V. (2018). Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget, 9 (12), 10665-10680. doi:10.18632/oncotarget.24366

Rademaker, G., Costanza, B., Bellier, J., Herfs, M., Agirman, F., Maloujahmoum, N., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin depletion induces DNA damage response and p53 dependent cell cycle arrest and apoptosis in colon cancer [Poster presentation]. Third Symposium of UBRC, Bruxelles, Belgium.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., Bellier, J., Costanza, B., Herfs, M., Bettendorff, L., Deroanne, C., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma and affects tumor aggressiveness [Poster presentation]. Bioforum Uliège.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Anania, S., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic cancer and affects tumor aggressiveness [Poster presentation]. Belgian Association for Cancer Research Congress.

Umelo, I. A., Costanza, B., & Castronovo, V. (2018). Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies. Cancer and Metastasis Reviews. doi:10.1007/s10555-017-9710-0

Hoge, A., Bernardy, F., Donneau, A.-F., Dardenne, N., Degée, S., TIMMERMANS, M., Nisolle, M., Guillaume, M., & Castronovo, V. (November 2017). Low omega-3 index values and monounsaturated fatty acid levels in early pregnancy: an analysis of maternal erythrocytes fatty acids [Paper presentation]. Journée doctorale EDT/SPSS.

Bellier, J., Nokin, M.-J., Durieux, F., Peulen, O., Uchida, K., Spiegel A, D., Cochrane R, J., Hutton A, C., Castronovo, V., & Bellahcene, A. (19 October 2017). Hormetic potential of Methylglyoxal in switching cancer cells from growth to death [Poster presentation]. Bellier, Bertinoro, Italy.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (22 September 2017). Myoferlin controls mitochondrial structure in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. Second U-CRC Symposium, Bruxelles, Belgium.

Hendrick, E., Peixoto, P., Blomme, A., Polese, C., Matheus, N., Cimino, J., Frère, A., Mouithys-Mickalad, A., Serteyn, D., Bettendorff, L., Elmoualij, B., De Tullio, P., Eppe, G., Dequiedt, F., Castronovo, V., & Mottet, D. (2017). Metabolic inhibitors accentuate the anti-tumoral effect of HDAC5 inhibition. Oncogene. doi:10.1038/onc.2017.103

Rademaker, G., Hennequière, V., Peixoto, P., Bellahcene, A., Castronovo, V., & Peulen, O. (01 February 2017). Myoferlin, a new autophagy player in pancreatic cancer cells [Poster presentation]. Giga-Day, Liège, Belgium.

Costanza, B., Umelo, I., Bellier, J., Turtoi, A., & Castronovo, V. (2017). Stromal Modulators of TGF-β in Cancer. Journal of Clinical Medicine. doi:10.3390/jcm6010007

Chiavarina, B., Nokin, M.-J., Bellier, J., Durieux, F., BLETARD, N., Sherer, F., LOVINFOSSE, P., Peulen, O., Verset, L., Dehon, R., Demetter, P., Turtoi, A., Uchida, K., Goldman, S., Hustinx, R., Delvenne, P., Castronovo, V., & Bellahcene, A. (2017). Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer. International Journal of Molecular Sciences, 18 (1). doi:10.3390/ijms18010213

Nokin, M.-J., Durieux, F., Bellier, J., Peulen, O., Uchida, K., Spiegel, D. A., Cochrane, J. R., Hutton, C. A., Castronovo, V., & Bellahcene, A. (2017). Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death. Scientific Reports, 7 (1), 11722. doi:10.1038/s41598-017-12119-7

Blomme, A., Fahmy, K., Peulen, O., Costanza, B., Fontaine, M., Struman, I., Baiwir, D., De Pauw, E., Thiry, M., Bellahcene, A., Castronovo, V.* , & Turtoi, A.*. (2016). Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes. Oncotarget. doi:10.18632/oncotarget.13276
* These authors have contributed equally to this work.

Blomme, A., Costanza, B., De Tullio, P., Thiry, M., Van Simaeys, G., Boutry, S., Doumont, G., Di Valentin, E., Hirano, T., Yokobori, T., GOFFLOT, S., Peulen, O., Bellahcene, A., Sherer, F., Le Goff, C., Cavalier, E., Mouithys-Mickalad, A., Jouret, F., CUSUMANO, G., ... Turtoi, A. (2016). Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer. Oncogene. doi:10.1038/onc.2016.369

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Scheijen, J., Schalkwijk, C., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., ... Bellahcene, A. (2016). Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP- mediated tumor growth and metastasis. eLife. doi:10.7554/eLife.19375

Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483

Henry, A., Nokin, M.-J., Leroi, N., LALLEMAND, F., Lambert, J., Goffart, N., Peixoto, P., Blomme, A., BIANCHI, E., Habraken, Y., RONCARATI, P., Peulen, O., SCHOLTES, F., MARTINIVE, P., Rogister, B., Delvenne, P., Turtoi, A., Castronovo, V., & Bellahcene, A. (22 March 2016). Osteopontin predicts radiotherapy response of glioblastoma patients : new role in DNA damage repair [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gand, Belgium.

Turtoi, A., Otaka, Y., Rokudai, S., Yokobori, T., Costanza, B., Oyama, T., Kuwano, H., DELWAIDE, J., DELVENNE, P., DETRY, O., Castronovo, V., & Nishiyama, M. (March 2016). Discovery of novel accessible proteins for therapeutic targeting of hepatocellular carcinoma. Acta Gastro-Enterologica Belgica, 79 (1), 13.

Blomme, A., Cusumano, P., Peulen, O., Bellahcene, A., Castronovo, V., & Turtoi, A. (2016). L'asporine : une nouvelle defense naturelle contre le cancer du sein. MS. Medecine Sciences, 32 (11), 1019-1022. doi:10.1051/medsci/20163211020

Costanza, B., Blomme, A., Bellahcene, A., Peulen, O., MUTIJIMA NZARAMBA, E., DELVENNE, P., De Pauw, E., DETRY, O., COIMBRA MARQUES, C., Castronovo, V., & Turtoi, A. (2016). EXPEL: A Novel Non-Destructive Method for Mining Soluble Tumor Biomarkers. Acta Gastro-Enterologica Belgica, 79 (1), 11.

Fahmy, K., Gonzalez, A., Arafa, M., Peixoto, P., Bellahcene, A., Turtoi, A., Delvenne, P., Thiry, M., Castronovo, V., & Peulen, O. (2016). Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer. International Journal of Cancer, 138, 652-663. doi:10.1002/ijc.29820

Fradet, A., Bouchet, M., Delliaux, C., Gervais, M., Kan, C., Benetollo, C., Pantano, F., Vargas, G., Bouazza, L., Croset, M., Bala, Y., Leroy, X., Rosol, T. J., Rieusset, J., Bellahcene, A., Castronovo, V., Aubin, J. E., Clezardin, P., Duterque-Coquillaud, M., & Bonnelye, E. (2016). Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone. Oncotarget, 7 (47), 77071-77086. doi:10.18632/oncotarget.12787

Peixoto, P.* , Blomme, A.* , Costanza, B.* , Ronca, R., Rezzola, S., Palacios, A., SCHOYSMAN, L., Boutry, S., Goffart, N., Peulen, O., Maris, P., Di Valentin, E., Hennequière, V., BIANCHI, E., Henry, A., Meunier, P., Rogister, B., MULLER, R., Delvenne, P., ... Turtoi, A. (2016). HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies. Oncogene. doi:10.1038/onc.2015.506
* These authors have contributed equally to this work.

Quemener, C., Baud, J., Boye, K., Dubrac, A., Billottet, C., Soulet, F., Darlot, F., Dumartin, L., Sire, M., Grepin, R., Daubon, T., Rayne, F., Wodrich, H., Couvelard, A., Pineau, R., Schilling, M., Castronovo, V., Sue, S.-C., Clarke, K., ... Bikfalvi, A. (2016). Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer. Cancer Research, 76 (22), 6507-6519. doi:10.1158/0008-5472.CAN-15-2864

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Eppe, G., Castronovo, V., & Mottet, D. (03 December 2015). Compensatory Metabolism Promotes Cancer Cell Adaptation to HDAC5 Silencing [Poster presentation]. Séminaires des chercheurs Télévie 2016, Gembloux, Belgium.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., Hutton, C., De Pauw, E., ... Bellahcene, A. (29 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Cancer and Metabolism Conference, Cambridge, United Kingdom.

Durieux, F., Peixoto, P., Chiavarina, B., Nokin, M.-J., Karoyan, P., Castronovo, V., & Bellahcene, A. (28 September 2015). Characterization of new carbonyl scavenger molecules and their subsequent use for cancer therapy [Poster presentation]. Cancer and Metabolism Abcam 2015 Conference, Cambridge, United Kingdom.

Henry, A., Bellahcene, A., Castronovo, V., Peixoto, P., Goffart, N., Lallemand, F., Leroi, N., Peulen, O., MARTINIVE, P., Habraken, Y., Turtoi, A., Rogister, B., & Blomme, A. (Other coll.). (10 September 2015). Osteopontin as a new target in glioblastoma progression and resistance to radiotherapy [Paper presentation]. II International Symposium on clinical and basic investigation in glioblastoma, Toledo, Spain.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Smargiasso, N., De Tullio, P., BIANCHI, E., Baiwir, D., Thiry, M., Turtoi, A., De Pauw, E., DELVENNE, P., Castronovo, V., & Bellahcene, A. (09 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Metabolism in Cancer and Stromal Cells, Leuven, Belgium.

Costanza, B., Blomme, A., MUTIJIMA NZARAMBA, E., DELVENNE, P., DETRY, O., Castronovo, V., & Turtoi, A. (March 2015). Expel: a novel non-destructive method for mining soluble tumor biomarkers. Acta Gastro-Enterologica Belgica, 78 (1), 13.

Perez Palacios, A., Blomme, A., Boutry, S., Doumont, G., Sherer, F., Van Simaeys, G., Debois, D., JERUSALEM, G., COLLIGNON, J., DELVENNE, P., DETRY, O., De Pauw, E., Muller, R., Goldman, S., Castronovo, V., & Turtoi, A. (March 2015). Metabolomic, proteomic and preclinical imaging of patient-derived tumor xenografts for improving treatment of liver metastases patients. Acta Gastro-Enterologica Belgica, 78 (1), 134.

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (11 February 2015). HDAC5 Depletion in Cancer Cells Induces an Oxidative Stress and Leads to a Metabolic Reprogramming toward Glucose and Glutamine Metabolism [Poster presentation]. Seminaires des chercheurs Télévie 2015, Bruxelles, Belgium.

Blomme, A., Costanza, B., Thiry, M., De Tullio, P., Perez-Palacios, A., Mouithys-Mickalad, A., LIFRANGE, E., Delvenne, P., Castronovo, V., & Turtoi, A. (31 January 2015). Myoferlin Regulates Endosomal Trafficking and Tunes Cancer Cell Metabolism [Poster presentation]. ASSOCIATION BELGE POUR L'ETUDE DU CANCER "A.B.E.C» ANNUAL MEETING 2015: TUMOR METABOLISM AND MITOCHONDRIA, Louvain, Belgium.

Fahmy, K., Peulen, O., Castronovo, V., Bellahcene, A., Turtoi, A., Thiry, M., Delvenne, P., PEIXOTO, P., Gonzalez, A., & ARAFA, M. (31 January 2015). Myoferlin: an indispensable component in VEGFA secretion by pancreas cancer cells [Poster presentation]. ASSOCIATION BELGE POUR L'ETUDE DU CANCER, Bruxelles, Belgium.

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (31 January 2015). HDAC5 Depletion in Cancer Cells Induces an Oxidative Stress and Leads to a Metabolic Reprogramming toward Glucose and Glutamine Metabolism [Poster presentation]. ABEC TUmor Metabolism and Mitochondria, Bruxelles, Belgium.

Blomme, A., Costanza, B., Thiry, M., De Tullio, P., Perez Palacios, A., LIFRANGE, E., DELVENNE, P., Castronovo, V., & Turtoi, A. (27 January 2015). Myoferlin regulates endosomal trafficking and tunes cancer cell metabolism [Poster presentation]. GIGA-DAY 2015: Current advances in medical genetics and genomics, Liège, Belgium.

Fahmy, K., Gonzalez, A., Arafad, M., Turtoi, A., Bellahcene, A., DELVENNE, P., Thiry, M., Castronovo, V., & Peulen, O. (27 January 2015). Myoferlin: an indispensable component in VEGR-A secretion by pancreatic cancer cell [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (27 January 2015). HDAC5 Depletion in Cancer Cells Induces an Oxidative Stress and Leads to a Metabolic Reprogramming toward Glucose and Glutamine Metabolism [Poster presentation]. Giga Cancer Day 2015 Current Advances in Medical Genetics and Genomics, Liège, Belgium.

Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Smargiasso, N., Baiwir, D., De Pauw, E., De Tullio, P., Thiry, M., Peulen, O., Turtoi, A., Castronovo, V., & Bellahcene, A. (27 January 2015). Accumulation of methylglyoxal, a glycolysis by-product modulates YAP1 transcription co-factor localization and activity in human breast cancer cells through HSP90 modification [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Lamour, V., Henry, A., Kroonen, J., Nokin, M.-J., von Marschall, Z., Fisher, L., Chau, T.-L., Chariot, A., Sanson, M., Delattre, J.-Y., Turtoi, A., Peulen, O., Rogister, B., Castronovo, V., & Bellahcene, A. (2015). Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. International Journal of Cancer. doi:10.1002/ijc.29454

Castronovo, C., Castronovo, V., Nikkels, A., & Peulen, O. (2015). LES ACTIVITES ANTI-CANCEREUSES DE LA VITAMINE D: les observations, les doutes et les certitudes. Revue Médicale de Liège, 70 (10), 495-500.

Maris, P., Blomme, A., Palacios, A. P., Costanza, B., Bellahcene, A., BIANCHI, E., GOFFLOT, S., Drion, P., Trombino, G. E., Di Valentin, E., CUSUMANO, G., MAWEJA, S., JERUSALEM, G., Delvenne, P., LIFRANGE, E., Castronovo, V., & Turtoi, A. (2015). Asporin Is a Fibroblast-Derived TGF-beta1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Medicine, 12 (9), 1001871. doi:10.1371/journal.pmed.1001871

Mskhiladze, L., Chincharadze, D., Tits, M., Wauters, J.-N., Bellahcene, A., Castronovo, V., Mouithys-Mickalad, A., Franck, T., & Frederich, M. (2015). Identification of Cytotoxic and Antioxidant Compounds from Allium gramineum Flowers. International Journal of Pharmaceutical Sciences and Drug Research, 7, 78-82.

Turtoi, A., Blomme, A., & Castronovo, V. (2015). Intratumoral heterogeneity and consequences for targeted therapies. Bulletin du Cancer, 102 (1), 17-23. doi:10.1016/j.bulcan.2014.12.006

Turtoi, A., Peixoto, P., Castronovo, V., & Bellahcene, A. (2015). Histone deacetylases and cancer-associated angiogenesis: current understanding of the biology and clinical perspectives. Critical Reviews in Oncogenesis, 20 (1-2), 119-37. doi:10.1615/CritRevOncog.2014012423

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (30 September 2014). HDAC5 Depletion in Cancer Cells Induces an Oxidative Stress and Leads to a Metabolic Reprogramming toward Glucose and Glutamine Metabolism [Paper presentation]. Annual Mini symposium 2014, Liège, Belgium.

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (25 September 2014). HDAC5 Depletion in Cancer Cells Induces an Oxidative Stress and Leads to a Metabolic Reprogramming toward Glucose and Glutamine Metabolism [Poster presentation]. Metabolism and Cancer Nice, Nice, France.

Chiavarina, B.* , Nokin, M.-J.* , Durieux, F., BIANCHI, E., Turtoi, A., Peulen, O., Peixoto, P., Irigaray, P., Uchida, K., Belpomme, D., Delvenne, P., Castronovo, V., & Bellahcene, A. (2014). Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes. Oncotarget. doi:10.18632/oncotarget.2121
* These authors have contributed equally to this work.

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (19 May 2014). Glucose-dependent metabolic reprogramming in HDAC5-depleted cancer cells [Poster presentation]. Giga Cancer Day 2014 THE LYMPHATIC SYSTEM : THE BED AND BENCH POINT OF VIEWS, Liège, Belgium.

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (25 April 2014). Glucose-dependent metabolic reprogramming in HDAC5-depleted cancer cells [Poster presentation]. Reactive Oxygen Species in Cell Metabolism 11th Meeting of the FRS-FNRS contact group on oxidative stress and anti-oxidants 210th Meeting of the Belgian Society of Biochemistry and Molecular Biology, Belgium.

Castronovo, V., Blomme, A., Delvenne, P., DETRY, O., & Turtoi, A. (March 2014). TGF-B induced protein IG-H3 is essential for the growth of human liver metastases. Acta Gastro-Enterologica Belgica, 77 (1), 05.

Turtoi, A., Blomme, A., Debois, D., SOMJA, J., De Pauw, E., DETRY, O., & Castronovo, V. (March 2014). Organized proteomic heterogeneity in colorectal liver metastases and implications for therapies. Acta Gastro-Enterologica Belgica, 77 (1), 07.

Turtoi, A., Blomme, A., Debois, D., SOMJA, J., Delvaux, D., Patsos, G., Di Valentin, E., Peulen, O., MUTIJIMA NZARAMBA, E., De Pauw, E., Delvenne, P., DETRY, O., & Castronovo, V. (March 2014). Organized Proteomic Heterogeneity in Colorectal Cancer Liver Metastases and Implications for Therapies. Hepatology, 59 (3), 924-934. doi:10.1002/hep.26608

Hendrick, E., Peixoto, P., Polese, C., Matheus, N., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Castronovo, V., & Mottet, D. (01 February 2014). Complex I Mitochondrial Dysfunction in HDAC5-depleted Cancer Cells Induces Glucose-dependent Metabolic Reprogramming [Poster presentation]. Association Belge pour l'étude du cancer A.B.E.C 2014, Anvers, Belgium.

CASTRONOVO, C., DECKERS, M., NIKKELS, A., Castronovo, V., & Peulen, O. (27 January 2014). Vitamin D receptor polymorphism and melanoma outcome [Poster presentation]. Giga-day, Liège, Belgium.

Hendrick, E., Peixoto, P., Matheus, N., Polese, C., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Sonveaux, P., Castronovo, V., & Mottet, D. (27 January 2014). Complex I Mitochondrial Dysfunction in HDAC5-depleted Cancer Cells Induces Glucose-dependent Metabolic Reprogramming [Poster presentation]. Giga Day 2014, Liège, Belgium.

Costanza, B., Blomme, A., Bellahcene, A., Hennequière, V., LIFRANGE, E., DELVENNE, P., Castronovo, V., & Turtoi, A. (2014). Myoferlin is a Key Regulator of HER Receptor Family Function in Breast Cancer [Paper presentation]. EDT Annual Mini symposium 2014.

Suarez-Carmona, M., Hubert, P., Gonzalez, A., Duray, A., RONCARATI, P., Erpicum, C., Boniver, J., Castronovo, V., Noël, A., Saussez, S., Peulen, O., Delvenne, P., & Herfs, M. (2014). DeltaNp63 isoform-mediated beta-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma. Oncotarget, 5 (7), 1856-1868. doi:10.18632/oncotarget.1819

Tilli, T. M., Bellahcene, A., Castronovo, V., & Gimba, E. R. P. (2014). Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines. BMC Cancer, 14, 433. doi:10.1186/1471-2407-14-433

Turtoi, A.* , Blomme, A.* , BIANCHI, E., Maris, P., Vannozzi, R., Naccarato, A. G., DELVENNE, P., De Pauw, E., Bevilacqua, G., & Castronovo, V. (2014). Accessibilome of human glioblastoma: collagen-VI-alpha-1 is a new target and a marker of poor outcome. Journal of Proteome Research, 13 (12), 5660-5669. doi:10.1021/pr500657w
* These authors have contributed equally to this work.

Hendrick, E., Matheus, N., Peixoto, P., Polese, C., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., Elmoualij, B., De Tullio, P., Castronovo, V., & Mottet, D. (05 December 2013). HDAC5 depletion Decreases NDUFB5 Subunit of Mitochondrial Complex- I leading to Glucose-dependent Metabolic Reprogrammation [Poster presentation]. Séminaire des chercheurs Télévie 2014, Bruxelles, Belgium.

Hendrick, E., Matheus, N., Peixoto, P., Polese, C., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Castronovo, V., & Mottet, D. (13 September 2013). Complexe I mitochondrial dysfunction in HDAC5 depleted cancer cells induces glucose-dependent metabolic reprogrammation [Poster presentation]. Annual Mini symposium 2013, Bruxelles, Belgium.

Peulen, O.* , Gonzalez, A.* , Peixoto, P., Turtoi, A., Mottet, D., Delvenne, P., & Castronovo, V. (11 September 2013). The Anti-Tumor Effect of HDAC Inhibition in a Human Pancreas Cancer Model Is Significantly Improved by the Simultaneous Inhibition of Cyclooxygenase 2. PLoS ONE, 8 (9), 75102. doi:10.1371/journal.pone.0075102
* These authors have contributed equally to this work.

Novo, C. L., Polese, C., Matheus, N., Decottignies, A., Londono-Vallejo, A., Castronovo, V., & Mottet, D. (September 2013). A new role for histone deacetylase 5 in the maintenance of long telomeres. FASEB Journal, 27. doi:10.1096/fj.12-224204

Warnock, G., Turtoi, A., Blomme, A., Bretin, F., Bahri, M. A., Lemaire, C., Libert, L., Seret, A., Luxen, A., Castronovo, V., & Plenevaux, A. (22 August 2013). In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: A new tool for oncology and radiotracer development. Journal of Nuclear Medicine, 54 (10), 1782-1788. doi:10.2967/jnumed.112.117150

Gonzalez, A., Peixoto, P., Turtoi, A., Mottet, D., Delvenne, P., Castronovo, V., & Peulen, O. (11 July 2013). Concomitant inhibition of class I HDAC and COX-2 exerts a antitumor effect in a human pancreatic cancer model [Poster presentation]. WIN2013 Symposium: "Personalized Cancer Therapy: from innovation to implemantation".

Hendrick, E., Matheus, N., Peixoto, P., Polese, C., Blomme, A., Mouithys-Mickalad, A., Serteyn, D., De Tullio, P., Elmoualij, B., Castronovo, V., & Mottet, D. (17 May 2013). Mitochondrial dysfunction in HDAC5-depleted cancer cells induces glucose-dependent metabolic adaptation [Poster presentation]. GIGA-Cancer Day 2013, Liège, Belgium.

Hendrick, E., Matheus, N., Peixoto, P., Polese, C., Mouithys-Mickalad, A., Serteyn, D., Michiels, C., Castronovo, V., & Mottet, D. (02 February 2013). JNK/ROS signaling pathway is responsible for induction of autophagy in HDAC5 depleted cancer cells [Poster presentation]. Association Belge pour l'étude du cancer A.B.E.C 2013, Gand, Belgium.

Hendrick, E., Matheus, N., Peixoto, P., Polese, C., Mouithys-Mickalad, A., Serteyn, D., Castronovo, V., & Mottet, D. (29 January 2013). JNK/ROS Signaling Pathway Is Responsible for Induction of Autophagy in HDAC5 depleted Cancer Cells [Paper presentation]. Journée Scientifique des doctorants en sciences Biomédicales et Pharmaceutiques, Mons, Belgium.

Hendrick, E., Matheus, N., Peixoto, P., Polese, C., Thiry, M., Mouithys-Mickalad, A., Serteyn, D., & Castronovo, V. (28 January 2013). JNK/ROS signaling pathway is responsible for induction of autophagy in HDAC5 depleted cancer cells [Poster presentation]. Giga Day 2013, Liège, Belgium.

Bournine, L., Bensalem, S., Peixoto, P., Gonzalez, A., Maiza-Benabdesselam, F., Bedjou, F., Wauters, J.-N., Tits, M., Frederich, M., Castronovo, V., & Bellahcene, A. (2013). Revealing the anti-tumoral effect of Algerian Glaucium flavum roots against human cancer cells. Phytomedicine, 20 (13), 1211-1218. doi:10.1016/j.phymed.2013.06.007

bournine, L., Bensalem, S., Wauters, J.-N., Iguer-Ouada, M., Maiza-Benabdesselam, F., Bedjou, F., Castronovo, V., Bellahcene, A., Tits, M., & Frederich, M. (2013). Identification and Quantification of the Main Active Anticancer Alkaloids from the Root of Glaucium flavum. International Journal of Molecular Sciences, 14, 23533-23544. doi:10.3390/ijms141223533

Calligaris, D., Longuespée, R., Debois, D., Asakawa, D., Turtoi, A., Castronovo, V., Noël, A., Bertrand, V., De Pauw-Gillet, M.-C., & De Pauw, E. (2013). Selected Protein Monitoring in Histological Sections by Targeted MALDI-FTICR in-source decay Imaging. Analytical Chemistry, 85 (4), 2117-26. doi:10.1021/ac302746t

Fradet, A., Sorel, H., Depalle, B., Serre, C. M., Farlay, D., Turtoi, A., Bellahcene, A., Follet, H., Castronovo, V., Clezardin, P., & Bonnelye, E. (2013). A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer. PLoS ONE, 8 (9), 75092. doi:10.1371/journal.pone.0075092

Lamour, V., Nokin, M.-J., Henry, A., Castronovo, V., & Bellahcene, A. (2013). Les proteines SIBLING - Outils moleculaires de la progression tumorale et de l'angiogenese. MS. Medecine Sciences, 29 (11), 1018-25. doi:10.1051/medsci/20132911019

Turtoi, A.* , Blomme, A.* , Bellahcene, A., Gilles, C., Hennequière, V., Peixoto, P., BIANCHI, E., Noël, A., De Pauw, E., LIFRANGE, E., Delvenne, P., & Castronovo, V. (2013). Myoferlin is a key regulator of EGFR activity in breast cancer. Cancer Research, 73, 5438-5448. doi:10.1158/0008-5472.CAN-13-1142
* These authors have contributed equally to this work.

Hendrick, E., Peixoto, P., Matheus, N., Polese, C., Castronovo, V., & Mottet, D. (10 December 2012). Role of HDAC5 depletion induced autophagy on cancer cell death [Poster presentation]. Séminaires des chercheurs Télévie 2013, Liège, Belgium.

Warnock, G., Turtoi, A., Blomme, A., Gonzalez, A., Bretin, F., Bahri, M. A., Lemaire, C., Seret, A., Castronovo, V., Luxen, A., & Plenevaux, A. (October 2012). In Ovo PET Imaging Of A Human Colorectal Carcinoma Model In Chicken Chorioallantoic Membrane [Poster presentation]. Annual Congress of the European Association of Nuclear Imaging, Milan, Italy.

Blomme, A., Turtoi, A., & Castronovo, V. (September 2012). Imaging Guided Proteomics Unveils Heterogeneity in Colorectal Carcinoma Liver Metastases – Implications for Targeted Therapies [Paper presentation]. HUPO Meeting 2012, Boston, United States.

Castronovo, V., & Turtoi, A. (21 June 2012). Biomarkers, uses of biomarkers and a method of identifying biomarkers for colorectal carcinoma (CRC) liver metastasis.

Castronovo, V., & Turtoi, A. (21 June 2012). Biomarkers, uses of biomarkers and a method of identifying biomarkers.

Calligaris, D., Debois, D., Turtoi, A., Castronovo, V., Noël, A., & De Pauw, E. (23 May 2012). A Promising Perspective for Pathologies Diagnosis by MALDI In-Source Decay Imaging with a FTMS System [Poster presentation]. 60th ASMS Conference on Mass Spectrometry, Vancouver, Canada.

Blomme, A., Turtoi, A., Delvaux, D., Patsos, G., Somja, J., Debois, D., Delvenne, P., Warnock, G., Plenevaux, A., Luxen, A., Drion, P., DETRY, O., De Pauw, E., & Castronovo, V. (2012). Imaging Guided Proteomics Unveils Heterogeniety in Colorectal Carcinoma Liver Metastases – Implications for Targeted Therapies. In Proceedings Giga Day 2012.

Turtoi, A., Blomme, A., Delvaux, D., Dumont, B., SOMJA, J., Debois, D., DELVENNE, P., De Pauw, E., DE ROOVER, A., Honoré, P., DETRY, O., & Castronovo, V. (May 2012). INTRA-TUMORAL HETEROGENEITY AND RATIONAL SELECTION OF ANTIGENS FOR TARGETED THERAPY OF LIVER METASTASES. Acta Chirurgica Belgica, 112 (3), 89.FP53.

Turtoi, A., Blomme, A., & Castronovo, V. (24 April 2012). Rational selection of antigens for targeted therapy of liver metastases [Paper presentation]. Experimental Biology 2012, SAN DIEGO, United States.

Castronovo, V. (23 April 2012). Inflammation as the key link between obesity, metabolic syndrome, and cancer [Paper presentation]. Experimental Biology 2012, SAN DIEGO, United States.

Castronovo, V., Matheus, N., Dumont, B., Peixoto, P., Hennequière, V., Deroanne, C., Colige, A., De Pauw, E., Bellahcene, A., Mottet, D., & Turtoi, A. (21 April 2012). The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells [Paper presentation]. Experimental Biology 2012, SAN DIEGO, United States.

Peixoto, P., Matheus, N., Polese, C., gonzalez, A., Castronovo, V., & Mottet, D. (04 February 2012). HDAC5 is required for maintenance of pericentric heterochromatin and controls cell cycle progression of human cancer cells [Poster presentation]. Belgian Association for Cancer Research Annual Meeting 2012.

Castronovo, V., Bellahcene, A., & Pirotte, S. (02 February 2012). Dentin Matrix Protein 1 (DMP1) for use in pharmaceutical compositions.

Dumont, B., Castronovo, V., Peulen, O., BLETARD, N., Clézardin, P., Delvenne, P., De Pauw, E., Turtoi, A., & Bellahcene, A. (2012). Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis. Journal of Proteome Research. doi:10.1021/pr201022n

Hulin, A., Deroanne, C., Lambert, C., Dumont, B., Castronovo, V., Defraigne, J.-O., Nusgens, B., RADERMECKER, M., & Colige, A. (27 January 2012). Metallothionein-dependent up-regulation of TGF-B2 participates in the remodelling of the myxomatous mitral valve. Cardiovascular Research, 93 (3), 480-9.

Castronovo, V., Gonzalez, A., Delvenne, P., & Peulen, O. (2012). Development of a new chick chorioallantoic membrane model for human pancreas adenocarcinoma [Paper presentation]. Experimental Biology 2012, San Diego, United States - California.

Castronovo, V., Gonzalez, A., Delvenne, P., & Peulen, O. (2012). Development of a new chick chorioallantoic membrane model for human pancreas adenocarcinoma [Poster presentation]. Experimental Biology 2012, San Diego, United States - California.

Kischel, P., Bellahcene, A., Deux, B., Lamour, V., Dobson, R., De Pauw, E., Clezardin, P., & Castronovo, V. (2012). Overexpression of CD9 in human breast cancer cells promotes the development of bone metastases. Anticancer Research, 32 (12), 5211-20.

Mathieu, V., de Lassalle, E. M., Toelen, J., Mohr, T., Bellahcene, A., Van, G., Verschuere, T., Bouzin, C., Debyser, Z., De Vleesschouwer, S., Van Gool, S., Poirier, F., Castronovo, V., Kiss, R., & Feron, O. (2012). Galectin-1 in Melanoma Biology and Related Neo-Angiogenesis Processes. Journal of Investigative Dermatology. doi:10.1038/jid.2012.142

Peixoto, P., Castronovo, V., Matheus, N., Polese, C., Peulen, O., Gonzalez, A., Boxus, M., Verdin, E., Thiry, M., Dequiedt, F., & Mottet, D. (2012). Implication of HDAC-5 in heterochromatin replication [Poster presentation]. GIGA-DAY.

Peixoto, P., Castronovo, V., Matheus, N., Polese, C., Peulen, O., Gonzalez, A., Boxus, M., Verdin, E., Thiry, M., Dequiedt, F., & Mottet, D. (2012). HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells. Cell Death and Differentiation. doi:10.1038/cdd.2012.3

Peixoto, P., Castronovo, V., Matheus, N., Polese, C., Peulen, O., Gonzalez, A., Boxus, M., Verdin, E., Thiry, M., Dequiedt, F., & Mottet, D. (2012). HDAC5 depletion modulates heterochromatin plasticity and triggers programmed cell death of human cancer cells [Poster presentation]. GIGA-DAY.

Tilli, T. M., Mello, K. D., Ferreira, L. B., Matos, A. R., Accioly, M. T., Faria, P. A., Bellahcene, A., Castronovo, V., & Gimba, E. R. (2012). Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells. Prostate. doi:10.1002/pros.22523

Turtoi, A., & Castronovo, V. (2012). Isotopically labeled proteome as an internal standard for multiple reaction monitoring-based biomarker quantification. Expert Review of Proteomics, 9 (3), 245-8. doi:10.1586/epr.12.27

Turtoi, A., Mottet, D., Matheus, N., Dumont, B., Peixoto, P., Hennequière, V., Deroanne, C., Colige, A., De Pauw, E., Bellahcene, A., & Castronovo, V. (2012). The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells. Angiogenesis. doi:10.1007/s10456-012-9279-8

Turtoi, A., Musmeci, D., Naccarato, A. G., Scatena, C., Ortenzi, V., Kiss, R., Murtas, D., Patsos, G., Mazzucchelli, G., De Pauw, E., Bevilacqua, G., & Castronovo, V. (2012). Sparc-like protein 1 is a new marker of human glioma progression. Journal of Proteome Research, 11 (10), 5011-21. doi:10.1021/pr3005698

Turtoi, A., Musmeci, D., Wang, Y., Dumont, B., Somja, J., Bevilacqua, G., De Pauw, E., Delvenne, P., & Castronovo, V. (02 September 2011). Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma. Journal of Proteome Research, 10 (9), 4302-13. doi:10.1021/pr200527z

Turtoi, A., Dumont, B., Greffe, Y., Blomme, A., Mazzucchelli, G., Delvenne, P., MUTIJIMA NZARAMBA, E., LIFRANGE, E., De Pauw, E., & Castronovo, V. (01 July 2011). Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues. Journal of Proteome Research, 10 (7), 3160-82. doi:10.1021/pr200212r

Castronovo, V., Blomme, A., Dumont, B., & Turtoi, A. (2011). Development of Targeted Therapies for Liver Metastases: Is Heterogeneity a Major Issue? [Paper presentation]. Annual Meeting at Experimental Biology, Washington DC, United States.

Peixoto, P., Pirotte, S., Matheus, N., Castronovo, V., & Mottet, D. (05 February 2011). Histone deacetylase 5 is a regulator of S phase progression [Poster presentation]. Belgian Association for Cancer Research Annual Meeting, Liège, Belgium.

Fradet, A., Sorel, H., Bouazza, L., Goehrig, D., Depalle, B., Bellahcene, A., Castronovo, V., Follet, H., Descotes, F., Aubin, J. E., Clezardin, P., & Bonnelye, E. (2011). Dual function of ERR alpha in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. Cancer Research, 71 (17), 5728-38. doi:10.1158/0008-5472.CAN-11-1431

Kischel, P., Waltregny, D., Greffe, Y., Mazzucchelli, G., De Pauw, E., de Leval, L., & Castronovo, V. (2011). Identification of stromal proteins overexpressed in nodular sclerosis Hodgkin lymphoma. Proteome Science, 9 (1), 63. doi:10.1186/1477-5956-9-63

NIZET, J.-L., Gonzalez, A., Peulen, O., & Castronovo, V. (2011). Transferts graisseux au niveau du sein: implications oncologiques. Revue Médicale de Liège, 66 (5-6), 362-6.

Pirotte, S., Lamour, V., Lambert, V., Alvarez Gonzalez, M.-L., Ormenese, S., Noël, A., Mottet, D., Castronovo, V., & Bellahcene, A. (2011). Dentin Matrix Protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation. Blood, 117 (8), 2515-26. doi:10.1182/blood-2010-08-298810

Sin, S., Bonin, F., Petit, V., Meseure, D., Lallemand, F., Bieche, I., Bellahcene, A., Castronovo, V., de Wever, O., Gespach, C., Lidereau, R., & Driouch, K. (2011). Role of the Focal Adhesion Protein Kindlin-1 in Breast Cancer Growth and Lung Metastasis. Journal of the National Cancer Institute, 103, 1-15. doi:10.1093/jnci/djr290

Stresing, V., Fournier, P. G., Bellahcene, A., Benzaid, I., Monkkonen, H., Colombel, M., Ebetino, F. H., Castronovo, V., & Clezardin. (2011). Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase. BONE, 48 (2), 259-66. doi:10.1016/j.bone.2010.09.035

Turtoi, A., De Pauw, E., & Castronovo, V. (January 2011). Innovative Proteomics for the Discovery of Systemically Accessible Cancer Biomarkers Suitable for Imaging and Targeted Therapies. American Journal of Pathology, 178 (1), 12-18. doi:10.1016/j.ajpath.2010.08.004

Mottet, D., & Castronovo, V. (December 2010). Histone deacetylases: anti-angiogenic targets in cancer therapy. Current Cancer Drug Targets, 10 (8), 898-913. doi:10.2174/156800910793358014

Fleron, M., Greffe, Y., Musmeci, D., Massart, A.-C., Hennequière, V., Mazzucchelli, G., Waltregny, D., De Pauw-Gillet, M.-C., De Pauw, E., Castronovo, V., & Turtoi, A. (10 September 2010). Novel post-digest isotope coded protein labeling method for phospho- and glycoproteome analysis. Journal of Proteomics, 73 (10), 1986-2005. doi:10.1016/j.jprot.2010.06.003

Castronovo, V., Waltregny, D., & Kischel, P. (07 July 2010). An in-vitro method for screening accessible biological markers in pathologic tissues.

Fleron, M., Greffe, Y., Massart, A.-C., Hennequière, V., Musmeci, D., Mazzucchelli, G., De Pauw-Gillet, M.-C., Castronovo, V., De Pauw, E., & Turtoi, A. (16 April 2010). Novel Relative ICPL Based Quantitative Phospho- and Glycoproteome Analysis Method [Poster presentation]. Belgian Society for Mass Spectrometry : Annual Meeting 2010, Leuven, Belgium.

Dumartin, L., Quemener, C., Laklai, H., Herbert, J., Bicknell, R., Bousquet, C., Pyronnet, S., Castronovo, V., Schilling, M. K., Bikfalvi, A., & Hagedorn, M. (April 2010). Netrin-1 Mediates Early Events in Pancreatic Adenocarcinoma Progression, Acting on Tumor and Endothelial Cells. Gastroenterology, 138 (4), 1595-606. doi:10.1053/j.gastro.2009.12.061

Castronovo, V., Wang, Y. H., Musmeci, D., Dumont, B., & Turtoi, A. (2010). Proteomic analysis of human pancreas cancers for the identification of targetable biomarkers [Paper presentation]. Federation of American Societies for Experimental Biology, Steamboat Springs, Colorado, United States.

Kischel, P., Waltregny, D., Dumont, B., Turtoi, A., Greffe, Y., Kirsch, S., De Pauw, E., & Castronovo, V. (2010). Versican overexpression in human breast cancer lesions: Known and new isoforms for stromal tumor targeting. International Journal of Cancer, 126 (3), 640-50. doi:10.1002/ijc.24812

Lamour, V., Le Mercier, M., Lefranc, F., Hagedorn, M., Javerzat, S., Bikfalvi, A., Kiss, R., Castronovo, V., & Bellahcene, A. (2010). Selective osteopontin knockdown exerts anti-tumoral activity in a human glioblastoma model. International Journal of Cancer, 126, 1797-1805. doi:10.1002/ijc.24751

Shiva Shankar, T. V., Sulka, B., Blacher, S., Maillard, C., Noël, A., Bellahcene, A., Castronovo, V., Lambert, D., Wouters, J., & Willems, L. (2010). Novel HDAC/DNMT twin inhibitors interfere with angiogenesis [Poster presentation]. Keystone Symposia on Molecular and Cellular Biology.

Castronovo, V., Waltregny, D., Detry, O., Coimbra Marques, C., De Roover, A., Honore, P., De Pauw, E., & Turtoi, A. (October 2009). Le ciblage therapeutique: vers une guerre propre et efficace contre le cancer [Paper presentation]. Journée Synthèse 2009 CHU La recherche translationnelle au CHU de Liège, Liège, Belgium.

Ayala, I., Giacchetti, G., Caldieri, G., Attanasio, F., Mariggio, S., Tete, S., Polishchuk, R., Castronovo, V., & Buccione, R. (2009). Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer. Cancer Research, 69 (3), 747-52. doi:10.1158/0008-5472.CAN-08-1980

Castronovo, V., Waltregny, D., Detry, O., Coimbra Marques, C., De Roover, A., Honore, P., De Pauw, E., & Turtoi, A. (2009). Le ciblage thérapeutique : vers une guerre propre et efficace contre le cancer. Revue Médicale de Liège, 64, 20-23.

Mottet, D., Pirotte, S., Lamour, V., Hagedorn, M., Javerzat, S., Bikfalvi, A., Bellahcene, A., Castronovo, V., & Verdin, E. (2009). HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene, 28 (2), 243-56. doi:10.1038/onc.2008.371

Bellahcene, A., Castronovo, V., Ogbureke, K. U., Fisher, L. W., & Fedarko, N. S. (March 2008). Small Integrin-Binding Ligand N-Linked Glycoproteins (Siblings): Multifunctional Proteins in Cancer. Nature Reviews. Cancer, 8 (3), 212-26. doi:10.1038/nrc2345

Detry, C., Lamour, V., Castronovo, V., & Bellahcene, A. (February 2008). Creb-1 and Ap-1 Transcription Factors Jund and Fra-2 Regulate Bone Sialoprotein Gene Expression in Human Breast Cancer Cells. BONE, 42 (2), 422-31. doi:10.1016/j.bone.2007.10.016

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., Delcour, J.-P., Crielaard, J.-M., & Henrotin, Y. (February 2008). Phenotypic Characterization of Osteoblasts from the Sclerotic Zones of Osteoarthritic Subchondral Bone. Arthritis and Rheumatism, 58 (2), 442-55. doi:10.1002/art.23159

Conrotto, P., Roesli, C., Rybak, J., Kischel, P., Waltregny, D., Neri, D., & Castronovo, V. (2008). Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis. International Journal of Cancer, 123 (12), 2856-2864. doi:10.1002/ijc.23861

Conrotto, P., Roesli, C., Rybak, J., Kischel, P., Waltregny, D., Neri, D., & Castronovo, V. (2008). Identification and characterization of new blood-accessible colorectal cancer biomarkers [Paper presentation]. 7th annual world congress of Human Proteome Organization (HUPO), Amsterdam, Netherlands.

Kischel, P., Greffe, Y., Waltregny, D., Chrétien, N., Mazzucchelli, G., De Pauw, E., de Leval, L., & Castronovo, V. (2008). Contribution of glycoproteomics in the search for accessible biomarkers in human lymphoma [Paper presentation]. FNRS Contact Group Proteomics (GCProt) 4th annual meeting: Chromatin Modifications and Protein Glycosylation, Louvain-la-Neuve, Belgium.

Kischel, P., Guillonneau, F., Dumont, B., Bellahcene, A., Stresing, V., Clezardin, P., De Pauw, E., & Castronovo, V. (2008). Cell membrane proteomic analysis identifies proteins differentially expressed in osteotropic human breast cancer cells. Neoplasia, 10 (9), 1014-20. doi:10.1593/neo.08570

Landemaine, T., Jackson, A., Bellahcene, A., Rucci, N., Sin, S., Abad, B. M., Sierra, A., Boudinet, A., Guinebretiere, J.-M., Ricevuto, E., Nogues, C., Briffod, M., Bieche, I., Cherel, P., Garcia, T., Castronovo, V., Teti, A., Lidereau, R., & Driouch, K. (2008). A six-gene signature predicting breast cancer lung metastasis. Cancer Research, 68 (15), 6092-9. doi:10.1158/0008-5472.CAN-08-0436

Mottet, D., & Castronovo, V. (2008). Les histones desacetylases : nouvelles cibles pour les therapies anti-cancereuses. MS. Medecine Sciences, 24 (8-9), 742-6. doi:10.1051/medsci/20082489742

Saidi, A., Javerzat, S., Bellahcene, A., De Vos, J., Bello, L., Castronovo, V., Deprez, M., Loiseau, H., Bikfalvi, A., & Hagedorn, M. (2008). Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. International Journal of Cancer, 122 (10), 2187-98. doi:10.1002/ijc.23313

Lamour, V., Detry, C., Sanchez, C., Henrotin, Y., Castronovo, V., & Bellahcene, A. (14 December 2007). Runx2-and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression. Journal of Biological Chemistry, 282 (50), 36240-36249. doi:10.1074/jbc.M705833200

Mottet, D., Bellahcene, A., Pirotte, S., Waltregny, D., Deroanne, C., Lamour, V., Lidereau, R., & Castronovo, V. (07 December 2007). Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis. Circulation Research, 101 (12), 1237-1246. doi:10.1161/CIRCRESAHA.107.149377

Mottet, D., & Castronovo, V. (2007). Histone Deacetylases: Target Enzymes for Cancer Therapy. Clinical and Experimental Metastasis. doi:10.1007/s10585-007-9131-5

Kischel, P., Waltregny, D., & Castronovo, V. (December 2007). Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies. Expert Review of Proteomics, 4 (6), 727-739. doi:10.1586/14789450.4.6.727

Ahuja, N., Schwer, B., Carobbio, S., Waltregny, D., North, B. J., Castronovo, V., Maechler, P., & Verdin, E. (16 November 2007). Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. Journal of Biological Chemistry, 282 (46). doi:10.1074/jbc.M705488200

Le Gall, C., Bellahcene, A., Bonnelye, E., Gasser, J. A., Castronovo, V., Green, J., Zimmermann, J., & Clezardin, P. (15 October 2007). A cathepsin K inhibitor reduces breast cancer-induced osteolysis and skeletal tumor burden. Cancer Research, 67 (20), 9894-9902. doi:10.1158/0008-5472.CAN-06-3940

Glenisson, W., Castronovo, V., & Waltregny, D. (October 2007). Histone deacetylase 4 is required for TGF beta 1-induced myofibroblastic differentiation. BBA Molecular Cell Research, 1773 (10), 1572-1582. doi:10.1016/j.bbamcr.2007.05.016

Bucciarelli, E., Sidoni, A., Bellezza, G., Cavaliere, A., Brachelente, G., Costa, G., Chaplet, M., Castronovo, V., & Bellahcene, A. (September 2007). Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro. Breast Cancer Research and Treatment, 105 (1), 95-104. doi:10.1007/s10549-006-9436-0

Castronovo, V., Kischel, P., Guillonneau, F., de Leval, L., Defechereux, T., De Pauw, E., Neri, D., & Waltregny, D. (April 2007). Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method. Proteomics, 7 (8), 1188-1196. doi:10.1002/pmic.200600888

Stabile, H., Mitola, S., Moroni, E., Belleri, M., Nicoli, S., Coltrini, D., Peri, F., Pessi, A., Orsatti, L., Talamo, F., Castronovo, V., Waltregny, D., Cotelli, F., Ribatti, D., & Presta, M. (01 March 2007). Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood, 109 (5), 1834-1840. doi:10.1182/blood-2006-06-032276

Bellahcene, A., Bachelier, R., Detry, C., Lidereau, R., Clezardin, P., & Castronovo, V. (January 2007). Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Breast Cancer Research and Treatment, 101 (2), 135-148. doi:10.1007/s10549-006-9279-8

Bellahcene, A., Chaplet, M., Bonjean, K., & Castronovo, V. (2007). Zoledronate inhibits alpha v beta 3 and alpha v beta 5 integrin cell surface expression in endothelial cells. Endothelium: Journal of Endothelial Cell Research, 14 (2), 123-130. doi:10.1080/10623320701347187

Glénisson, W., Waltregny, D., & Castronovo, V. (2007). Study of the role of histone deacetylases in myofibroblastic differenciation [Paper presentation]. Spring meeting of the Belgian Society for Cell and Developmental Biology, Liège, Belgium.

Glénisson, W., Waltregny, D., & Castronovo, V. (2007). Study of the role of histone deacetylases in myofibroblastic differenciation [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2007). Phenotypic characterisation of osteoblasts from the sclerotic zone of human osteoarthritic subchondral bone [Poster presentation]. 27th European Workshop for Rheumatology Research, Barcelona, Spain.

Castronovo, V., Waltregny, D., Kischel, P., Roesli, C., Elia, G., Rybak, J. N., & Neri, D. (November 2006). A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer. Molecular and Cellular Proteomics, 5 (11), 2083-2091. doi:10.1074/mcp.M600164-MCP200

Dassesse, T., de Leval, X., de Leval, L., Pirotte, B., Castronovo, V., & Waltregny, D. (November 2006). Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage. European Urology, 50 (5), 1021-31, discussion 1031. doi:10.1016/j.eururo.2006.01.036

Delmulle, L., Bellahcene, A., Dhooge, W., Comhaire, F., Roelens, F., Huvaere, K., Heyerick, A., Castronovo, V., & De Keukeleire, D. (November 2006). Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine, 13 (9-10), 732-734. doi:10.1016/j.phymed.2006.01.001

de Leval, X., Dassesse, T., Dogné, J.-M., Waltregny, D., Bellahcene, A., Benoit, V., Pirotte, B., & Castronovo, V. (September 2006). Evaluation of original dual thromboxane A2 modulators as antiangiogenic agents. Journal of Pharmacology and Experimental Therapeutics, 318 (3), 1057-1067. doi:10.1124/jpet.106.101188

Wedel, T., Van Eys, G., Waltregny, D., Glenisson, W., Castronovo, V., & Vanderwinden, J.-M. (July 2006). Novel smooth muscle markers reveal abnormalities of the intestinal musculature in severe colorectal motility disorders. Neurogastroenterology and Motility, 18 (7), 526-538. doi:10.1111/j.1365-2982.2006.00781.x

de Leval, L., Waltregny, D., Boniver, J., Young, R., Castronovo, V., & Oliva, E. (March 2006). Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus. American Journal of Surgical Pathology, 30 (3), 319-327. doi:10.1097/01.pas.0000188029.63706.31

Verdin, E. M., Waltregny, D., & Castronovo, V. (02 February 2006). Methods of treating smooth muscle cell disorders.

Chaplet, M., Waltregny, D., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (February 2006). Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness. International Journal of Cancer, 118 (4), 850-856. doi:10.1002/ijc.21442

Waltregny, D., & Castronovo, V. (2006). The biology of HDAC8. New Jersey, United States: The Humana Press Inc.

Mottet, D., Bellahcene, A., Waltregny, D., Lidereau, R., & Castronovo, V. (20 January 2006). Histone deacetylase HDAC7 as a key regulator of the angiogenic process [Poster presentation]. Annual meeting of the European STROMA consortium, Paris, France.

Castronovo, V., Kischel, P., Guillonneau, F., de Leval, L., Deféchereux, T., De Pauw, E., Neri, D., & Waltregny, D. (2006). Identification of accessible proteins expressed in human breast cancer [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

Dassesse, T., de Leval, X., Dogné, J.-M., Waltregny, D., Bellahcene, A., Pirotte, B., & Castronovo, V. (2006). Evaluation of original dual thromboxane A2 modulators as anti-angiogenic agents [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

Glénisson, W., Waltregny, D., & Castronovo, V. (2006). Study of the role of histone deacetylases in myofibroblastic differenciation [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

Glénisson, W., Waltregny, D., & Castronovo, V. (2006). Role of histone deacetylases in myofibroblastic differenciation [Paper presentation]. 8th meeting of the Interuniversity Attraction Pole (P5/31: Identification and functional analysis of Key Genes in Hormone-Sensitive Human Epithelial Tumors), Bruxelles, Belgium.

Glénisson, W., Waltregny, D., & Castronovo, V. (2006). Etude du rôle des histones déacétylases dans la différenciation myofibroblastique [Paper presentation]. Séminaire Télévie, Louvain-la-Neuve, Belgium.

Glénisson, W., Waltregny, D., Tran, S. L., North, B., Verdin, E., & Castronovo, V. (2006). Histone deacetylase HDAC8 associates with smooth muscle alpha–actin and is essential for smooth muscle cell contractility [Paper presentation]. 10th Bioforum, Liège, Belgium.

Mottet, D., Bellahcene, A., Deroanne, C., Lamour, V., Waltregny, D., & Castronovo, V. (2006). Histone deacetylase 7 is involved in the control of angiogenesis by regulating platelet-derived growth factor-β [Paper presentation]. Les Journées du CRCE, Liège, Belgium.

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2006). Phenotypic characterisation of osteoblasts from the sclerotic zone of human osteoarthritic subchondral bone. Osteoarthritis and Cartilage, 14 (Suppl B), 75.

Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2006). Caractérisation du phénotype des ostéoblastes issus des zones sclérosées de l’os sous-chondral arthrosique humain. Revue du Rhumatisme, 73 (10-11), 1058.

Timmermans, L., Kischel, P., Beckers, A., Vanderhoydonc, F., Organe, S., Brusselmans, K., Waltregny, D., Castronovo, V., Verhoeven, G., & Swinnen, J. (2006). Role of tumor-associated lipogenesis in the formation and composition of membrane microdomains [Paper presentation]. 10th meeting of the Interuniversity Attraction Pole (P5/31: Identification and functional analysis of Key Genes in Hormone-Sensitive Human Epithelial Tumors), Bruxelles, Belgium.

De Leval, X., Dassesse, T., Dogne, J. M., Castronovo, V., & Pirotte, B. (May 2005). Développement de modulateurs de la voie du thromboxane A2 en tant qu’agents anti-angiogéniques et anti-métastatiques [Poster presentation]. 19èmes Journées Franco-Belges de Pharmacochimie, Liège, Belgium.

Chaplet, M., Waltregny, D., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (2005). Dentin sialophosphoprotein expression correlates with progression markers in human prostate cancer [Paper presentation]. Meeting of the Paget’s foundation, Bethesda, MA, United States.

Chaplet, M., Waltregny, D., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (2005). Dentin sialophosphoprotein expression correlates with progression markers in human prostate cancer. Journal of Bone and Mineral Research, 20 (Suppl. 2), 45.

de Leval, L., Waltregny, D., Glenisson, W., Boniver, J., Young, R., Castronovo, V., & Oliva, E. (January 2005). Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the subclassification of mesenchymal tumors of the uterus, particularly epithelioid smooth muscle tumors. Modern Pathology, 18 (Suppl. 1), 180A-181.

Glénisson, W., Waltregny, D., Tran, S. L., North, B., Verdin, E., Colige, A., & Castronovo, V. (2005). Histone deacetylase HDAC8 associates with smooth muscle alpha–actin and is essential for smooth muscle cell contractility [Paper presentation]. Spring meeting of the Belgian Society for Cell and Developmental Biology, Louvain-la-Neuve, Belgium.

Waltregny, D., Chaplet, M., Detry, C., Fisher, L., Castronovo, V., & Bellahcene, A. (2005). Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness [Paper presentation]. Gordon Research Conference on SIBLINGs, Big Sky, MT, United States.

Waltregny, D., Glenisson, W., Tran, S. L., North, B., Verdin, E., Colige, A., & Castronovo, V. (2005). Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. FASEB Journal, 19 (8), 966-968. doi:10.1096/fj.04-2303fje

Chaplet, M., Deroanne, C., Fisher, L. W., Castronovo, V., Bellahcene, A., & Detry, C. (15 December 2004). Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition. Biochemical Journal, 384 (Pt 3), 591-598. doi:10.1042/BJ20040380

Califice, S., Waltregny, D., Castronovo, V., & van den Brule, F. (December 2004). Lignées de carcinome prostatique et apoptose: état de la question. Revue Médicale de Liège, 59 (12), 704-10.

Califice, S., Castronovo, V., & van den Brûle, F. (October 2004). Galectin-3 and Cancer (Review). International Journal of Oncology, 25 (4), 983-92.

Castronovo, V., Bracke, M., van den Brule, F., & Califice, S. (30 September 2004). Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene, 23 (45), 7527-7536. doi:10.1038/sj.onc.1207997

Waltregny, D., de Leval, L., Glenisson, W., Ly Tran, S., North, B., Bellahcene, A., Weidle, U., & Castronovo, V. (August 2004). Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. American Journal of Pathology, 165 (2), 553-564. doi:10.1016/S0002-9440(10)63320-2

De Leval, X., Dassesse, T., Benoit, V., Hanson, J., Dogne, J. M., Castronovo, V., & Pirotte, B. (May 2004). Development of thromboxane A2 modulators as promising anti-metastatic and anti-angiogenic compounds [Paper presentation]. 12th Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Castronovo, V. (2004). Tumor invasion and metastasis: getting more basic to come closer to the patient - An interview with Lance A. Liotta. International Journal of Developmental Biology, 48 (5-juin Sp. Iss. SI), 559-562. doi:10.1387/ijdb.041834vc

Glénisson, W., de Leval, L., Tran, S. L., Jackers, P., North, B., Verdin, E., Castronovo, V., & Waltregny, D. (2004). La déacétylase d’histones HDAC8 est un nouveau marqueur de différenciation des cellules musculaires lisses [Paper presentation]. Séminaire des jeunes chercheurs Télévie, Louvain-la-Neuve, Belgium.

Glénisson, W., Tran, S. L., Castronovo, V., & Waltregny, D. (2004). HDAC8 is required for myofibroblastic differentiation induced by TGFß [Paper presentation]. 11th Euregional Oncology meeting, Aachen, Germany.

Glénisson, W., Tran, S. L., Castronovo, V., & Waltregny, D. (2004). HDAC8 is necessary for TGFß-induced myofibroblastic differenciation W. Glénisson, S.L. Tran, V. Castronovo, D. Waltregny [Paper presentation]. 8th meeting of Interuniversity Attraction Pole (P5/31: Identification and functional analysis of Key Genes in Hormone-Sensitive Human Epithelial Tumors), Leuven, Belgium.

van den Brule, F., Califice, S., & Castronovo, V. (2004). Expression of Galectins in Cancer: A Critical Review. Glycoconjugate Journal, 19 (7-9), 537-42. doi:10.1023/B:GLYC.0000014083.48508.6a

Waltregny, D., North, B., Van Mellaert, F., de Leval, J., Verdin, E., & Castronovo, V. (2004). Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class IHDAC profiles between epithelial and stromal cells. European Journal of Histochemistry, 48 (3, Jul-Sep), 273-290.

De Leval, X., Dassesse, T., Benoît, V., Pirotte, B., Merville, M.-P., David, J. L., Castronovo, V., & Dogne, J. M. (December 2003). Pharmacological evaluation of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, as potential anti-metastatic agent [Poster presentation]. 45th ASH Annual Meeting, San Diego, United States.

de Leval, X. J., Dassesse, T., Benoit, V., Pirotte, B., Merville, M.-P., David, J.-L., Castronovo, V., & Dogné, J.-M. (16 November 2003). Pharmacological evaluation of BM-573, a dual thromboxane A(2) receptor antagonist and thromboxane synthase inhibitor, as potential anti-metastatic agent. Blood, 102 (11, Part 2), 72.

Chaplet, M., de Leval, L., Waltregny, D., Detry, C., Fornaciari, G., Bevilacqua, G., Fisher, L., Castronovo, V., & Bellahcene, A. (August 2003). Dentin matrix protein 1 is expressed in human lung cancer. Journal of Bone and Mineral Research, 18 (8), 1506-1512. doi:10.1359/jbmr.2003.18.8.1506

Detry, C., Waltregny, D., Quatresooz, P., Chaplet, M., Kedzia, W., Castronovo, V., Delvenne, P., & Bellahcene, A. (July 2003). Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix. Calcified Tissue International, 73 (1), 9-14. doi:10.1007/s00223-002-2108-0

Castronovo, V. (May 2003). Dépistage et détection précoce des cancers : Pourquoi? Comment? Lesquels? Qui et où? A quel prix? Revue Médicale de Liège, 58 (5), 310-3.

Castronovo, V. (April 2003). Alimentation et cancer. Revue Médicale de Liège, 58 (4), 231-9.

van den Brule, F., Califice, S., Garnier, F., Fernandez, P. L., Berchuck, A., & Castronovo, V. (March 2003). Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin. Laboratory Investigation, 83 (3), 377-386. doi:10.1097/01.LAB.0000059949.01480.40

Colin, A., Reggers, J., Castronovo, V., & Ansseau, M. (2003). Lipides, dépression et suicide. Encéphale (L'), 29 (1, JAN-FEB), 49-58.

De Leval, X., Dassesse, T., Benoit, V., Pirotte, B., David, J.-L., Merville, M.-P., Castronovo, V., & Dogné, J.-M. (2003). Pharmacological evaluation of BM-573, a dual thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, as potential anti-metastatic agent. Blood, 72.

Waltregny, D., Glénisson, W., Tran, S. L., Jackers, P., North, B., Weidle, U., Verdin, E., & Castronovo, V. (2003). Screening of histone deacetylase (HDAC) expression profiles in prostate cancer tissues leads to the identification of HDAC8 as a novel marker of smooth muscle differentiation [Paper presentation]. 6th annual meeting of ‘Innovators in Urology’, Amsterdam, Netherlands.

Modugno, M., Tagliabue, E., Ardini, E., Berno, V., Galmozzi, E., De Bortoli, M., Castronovo, V., & Menard, S. (24 October 2002). p53-dependent downregulation of metastasis-associated laminin receptor. Oncogene, 21 (49), 7478-7487. doi:10.1038/sj.onc.1205957

Wood, J., Bonjean, K., Ruetz, S., Bellahcene, A., Devy, L., Foidart, J.-M., Castronovo, V., & Green, J. R. (September 2002). Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. Journal of Pharmacology and Experimental Therapeutics, 302 (3), 1055-1061. doi:10.1124/jpet.102.035295

Waltregny, D., Alami, Y., Clausse, N., de Leval, J., & Castronovo, V. (February 2002). Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate, 50 (3), 162-169. doi:10.1002/pros.10045

Deroanne, C., Bonjean, K., Servotte, S., Devy, L., Colige, A., Clausse, N., Blacher, S., Verdin, E., Foidart, J.-M., Nusgens, B., & Castronovo, V. (17 January 2002). Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene, 21 (3), 427-436. doi:10.1038/sj.onc.1205108

Castronovo, V., Waltregny, D., Fisher, L., & Bellahcene, A. (2002). The role of bone sialoprotein and other members of the SIBLING family in bone metastases formation. In 3rd International Conference on Osteopontin and SIBLING (Small Integrin-Binding Ligand, N-linked Glycoprotein) Proteins (pp. 195-197). The Scientific World eBook. doi:10.1100/tsw.2002.323

Detry, C., Castronovo, V., Waltregny, D., Delvenne, P., & Bellahcene, A. (2002). Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Bruxelles, Belgium.

Locigno, R., Pincemail, J., Henno, A., Treusch, G., & Castronovo, V. (January 2002). S-acetyl-glutathione selectively induces apoptosis in human lymphoma cells through a GSH-independent mechanism. International Journal of Oncology, 20 (1), 69-75. doi:10.3892/ijo.20.1.69

Locigno, R., & Castronovo, V. (August 2001). Reduced Glutathione System: Role in Cancer Development, Prevention and Treatment (Review). International Journal of Oncology, 19 (2), 221-36. doi:10.3892/ijo.19.2.221

Verlaet, M., Deregowski, V., Denis, G., Humblet, C., Stalmans, M.-T., Bours, V., Castronovo, V., Boniver, J., & Defresne, M.-P. (27 April 2001). Genetic Imbalances in Preleukemic Thymuses. Biochemical and Biophysical Research Communications, 283 (1), 12-8. doi:10.1006/bbrc.2001.4731

Locigno, R., Henno, A., Waltregny, D., & Castronovo, V. (2001). Sodium butyrate and trichostatin-a induce apoptosis in human breast cancer cells but not in normal human mammary epithelial cells. Proceedings of the American Association for Cancer Research, 42, 635.

Locigno, R., Waltregny, D., Verheyen, V., Henno, A., & Castronovo, V. (January 2001). Sodium butyrate and trichostatin A induce growth arrest and apoptosis in breast cancer cells while normal breast epithelial cells are unaffected [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Bruxelles, Belgium.

van den Brule, F., Waltregny, D., & Castronovo, V. (January 2001). Increased Expression of Galectin-1 in Carcinoma-Associated Stroma Predicts Poor Outcome in Prostate Carcinoma Patients. Journal of Pathology, 193 (1), 80-7. doi:10.1002/1096-9896(2000)9999:9999<::AID-PATH730>3.0.CO;2-2

Waltregny, D., De Leval, L., Coppens, L., Youssef, E., De Leval, J., & Castronovo, V. (2001). Detection of the 67-kD laminin receptor in prostate cancer biopsies as a predictor of recurrence after radical prostatectomy. European Urology, 40 (5), 495-503. doi:10.1159/000049825

Bellahcene, A., Van Riet, I., de Greef, C., Antoine, N., Young, M. F., Van Camp, B., & Castronovo, V. (December 2000). Bone Sialoprotein Mrna and Protein Expression in Human Multiple Myeloma Cell Lines and Patients. British Journal of Haematology, 111 (4), 1118-21. doi:10.1046/j.1365-2141.2000.02506.x

van den Brule, F., Waltregny, D., Liu, F. T., & Castronovo, V. (20 July 2000). Alteration of the Cytoplasmic/Nuclear Expression Pattern of Galectin-3 Correlates with Prostate Carcinoma Progression. International Journal of Cancer, 89 (4), 361-7. doi:10.1002/1097-0215(20000720)89:4<361::AID-IJC8>3.3.CO;2-L

Waltregny, D., Bellahcene, A., de Leval, X., Florkin, B., Weidle, U., & Castronovo, V. (May 2000). Increased Expression of Bone Sialoprotein in Bone Metastases Compared with Visceral Metastases in Human Breast and Prostate Cancers. Journal of Bone and Mineral Research, 15 (5), 834-43. doi:10.1359/jbmr.2000.15.5.834

Bellahcene, A., Bonjean, K., Fohr, B., Fedarko, N. S., Robey, F. A., Young, M. F., Fisher, L. W., & Castronovo, V. (28 April 2000). Bone Sialoprotein Mediates Human Endothelial Cell Attachment and Migration and Promotes Angiogenesis. Circulation Research, 86 (8), 885-91. doi:10.1161/01.RES.86.8.885

Locigno, R., Antoine, N., Bours, V., Daukandt, M., Heinen, E., & Castronovo, V. (January 2000). Tnp-470, a Potent Angiogenesis Inhibitor, Amplifies Human T Lymphocyte Activation through an Induction of Nuclear Factor-Kappab, Nuclear Factor-at, and Activation Protein-1 Transcription Factors. Laboratory Investigation, 80 (1), 13-21. doi:10.1038/labinvest.3780003

van den Brule, F. A., Clausse, N., Delvenne, P., Franzen-Detrooz, E., & Castronovo, V. (January 2000). Combined Interferon-Gamma and Tumor Necrosis Factor-Alpha Treatment Differentially Affects Adhesion and Migration of Keratinocyte-Derived Cells to Laminin-1. Cell Adhesion and Communication, 7 (4), 321-9. doi:10.3109/15419060009015003

van den Brule, F., Waltregny, D., & Castronovo, V. (2000). Increased expression of Galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. Proceedings of the American Association for Cancer Research, 41, 386.

Waltregny, D., de Leval, L., Coppens, L., de Leval, J., & Castronovo, V. (2000). Detection of the 67-kD laminin receptor in prostate cancer biopsies as a predictor of recurrence after radical prostatectomy [Paper presentation]. 15th annual meeting of the European Association of Urology, Bruxelles, Belgium.

Castronovo, V., Liu, F. T., & van den Brule, F. A. (July 1999). Decreased Expression of Galectin-3 in Basal Cell Carcinoma of the Skin. International Journal of Oncology, 15 (1), 67-70.

Bellahcene, A., Waltregny, D., & Castronovo, V. (1999). The role of bone sialoprotein in bone metastasis. In G. G. Skouteris & G. L. Nicolson (Eds.), Intermolecular Cross-Talk in Tumor Metastasis. Amsterdam, Netherlands: IOS Press.

Alami, Y., Castronovo, V., Belotti, D., Flagiello, D., & Clausse, N. (21 April 1999). Hoxc5 and Hoxc8 Expression Are Selectively Turned on in Human Cervical Cancer Cells Compared to Normal Keratinocytes. Biochemical and Biophysical Research Communications, 257 (3), 738-45. doi:10.1006/bbrc.1999.0516

Bellahcene, A., Waltregny, D., & Castronovo, V. (1999). The role of bone sialoprotein in the process of bone metastases development. Amsterdam, Netherlands: IOS Press.

Bellahcene, A., Waltregny, D., & Castronovo, V. (1999). The role of bone sialoprotein in bone metastasis [Paper presentation]. 26th European Symposium on Calcified Tissues, Maastricht, Netherlands.

Castronovo, V., Dimitriadou, V., Savard, P., Rivière, M., & Dupont, E. (1999). Cartilage as a Source of Natural Inhibitors of Angiogenesis. In Antiangiogenic Agents in Cancer Therapy (pp. 175-183). Totowa, New Jersey, United States: Beverly A. Teicher. Humana Press.

Clausse, N., van den Brule, F., Waltregny, D., Garnier, F., & Castronovo, V. (1999). Galectin-1 Expression in Prostate Tumor-Associated Capillary Endothelial Cells Is Increased by Prostate Carcinoma Cells and Modulates Heterotypic Cell-Cell Adhesion. Angiogenesis, 3 (4), 317-25. doi:10.1023/A:1026584523789

Hlavcak, P., Sedlakova, O., Sedlak, J., Hunakova, L., Duraj, J., Sulikova, M., Bizik, J., Castronovo, V., & Chorvath, B. (1999). Cell surface immunophenotype and gelatinase activity of the human breast carcinoma cell line (MCF-7/6) with functionally defective E-cadherin. Neoplasma, 46 (1), 12-6.

Waltregny, D., Bellahcene, A., de Leval, X., & Castronovo, V. (1999). Increased expression of bone sialoprotein in skeletal metastases compared with non skeletal metastases from human breast and prostate cancers [Paper presentation]. Annual meeting of the Belgian Association for Cancer Research, Anvers, Belgium.

Clausse, N., van den Brûle, F., Delvenne, P., Jacobs, N., Franzen-Detrooz, E., Jackers, P., & Castronovo, V. (20 October 1998). Tnf-Alpha and Ifn-Gamma Down-Regulate the Expression of the Metastasis-Associated Bi-Functional 37lrp/P40 Gene and Protein in Transformed Keratinocytes. Biochemical and Biophysical Research Communications, 251 (2), 564-9. doi:10.1006/bbrc.1998.9431

Belotti, D., Clausse, N., Flagiello, D., Alami, Y., Daukandt, M., Deroanne, C., Malfoy, B., Boncinelli, E., Faiella, A., & Castronovo, V. (October 1998). Expression and Modulation of Homeobox Genes from Cluster B in Endothelial Cells. Laboratory Investigation, 78 (10), 1291-9.

Chariot, A., Senterre-Lesenfants, S., Sobel, M. E., & Castronovo, V. (01 October 1998). Molecular Cloning of a Mutated Hoxb7 Cdna Encoding a Truncated Transactivating Homeodomain-Containing Protein. Journal of Cellular Biochemistry, 71 (1), 46-54. doi:10.1002/(SICI)1097-4644(19981001)71:1<46::AID-JCB5>3.0.CO;2-1

van den Brule, F. A., Liu, F. T., & Castronovo, V. (September 1998). Transglutaminase-Mediated Oligomerization of Galectin-3 Modulates Human Melanoma Cell Interactions with Laminin. Cell Adhesion and Communication, 5 (6), 425-35. doi:10.3109/15419069809005601

Bellahcene, A., Albert, V., Pollina, L., Basolo, F., Fisher, L. W., & Castronovo, V. (August 1998). Ectopic Expression of Bone Sialoprotein in Human Thyroid Cancer. Thyroid, 8 (8), 637-41. doi:10.1089/thy.1998.8.637

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L. W., Young, M., Fernandez, P., Dewé, W., de Leval, J., & Castronovo, V. (01 July 1998). Prognostic Value of Bone Sialoprotein Expression in Clinically Localized Human Prostate Cancer. Journal of the National Cancer Institute, 90 (13), 1000-8. doi:10.1093/jnci/90.13.1000

Castronovo, V., Foidart, J.-M., & Boniver, J. (May 1998). Cancer du col de l'utérus: analyse du coût-bénéfice et de l'efficacité du dépistage opportuniste versus le dépistage organisé. Revue Médicale de Liège, 53 (5), 305-7.

Castronovo, V., & Bellahcene, A. (February 1998). Evidence That Breast Cancer Associated Microcalcifications Are Mineralized Malignant Cells. International Journal of Oncology, 12 (2), 305-8. doi:10.3892/ijo.12.2.305

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L., Fernandez, P., Dewé, de Leval, J., & Castronovo, V. (23 January 1998). Expression of bone sialoprotein in human prostate is associated with progression [Paper presentation]. 5th Euregional Oncology meeting, Maastricht, Netherlands.

Ardini, E., Pesole, G., Tagliabue, E., Magnifico, A., Castronovo, V., Sobel, M. E., Colnaghi, M. I., & Menard, S. (1998). The 67-kDa laminin receptor originated from a ribosomal protein that acquired a dual function during evolution. Molecular Biology and Evolution, 15 (8), 1017-25. doi:10.1093/oxfordjournals.molbev.a026000

Bellahcene, A., Albert, V., Nyabi, O., Cheung, N. K. V., Kramer, K., Waltregny, D., Fisher, L., & Castronovo, V. (1998). Bone sialoprotein is expressed in both human neuroblastoma tissues and cell lines. Proceedings of the American Association for Cancer Research, 39, 209.

Belotti, D., & Castronovo, V. (1998). Tumor angiogenesis : basis for new prognostic factors and new anticancer therapies. In Clinical and Biological Basis of Lung Cancer Prevention (pp. 95-103). Basel, Switzerland: Birkhaüser.

Buto, S., Tagliabue, E., Ardini, E., Magnifico, A., Ghirelli, C., van den Brule, F., Castronovo, V., Colnaghi, M. I., Sobel, M. E., & Menard, S. (1998). Formation of the 67-kDa laminin receptor by acylation of the precursor. Journal of Cellular Biochemistry, 69 (3), 244-51. doi:10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R

Sarafian, V., Jadot, M., Foidart, J.-M., Letesson, J. J., Van den Brule, F., Castronovo, V., Wattiaux, R., & Coninck, S. W. (1998). Expression of Lamp-1 and Lamp-2 and their interactions with galectin-3 in human tumor cells. International Journal of Cancer, 75 (1), 105-11. doi:10.1002/(SICI)1097-0215(19980105)75:1<105::AID-IJC16>3.0.CO;2-F

Waltregny, D., Bellahcene, A., de Leval, X., & Castronovo, V. (1998). Detection of bone sialoprotein in primary and metastatic lesions of human breast and prostate carcinomas, the two major osteotropic cancers. Revue du Rhumatisme, 7-9, 527.

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L., Fernandez, P., Dewé, W., de Leval, J., & Castronovo, V. (1998). Expression of bone sialoprotein in human prostate cancer is associated with progression. Proceedings of the American Association for Cancer Research, 39, 322.

Waltregny, D., Bellahcene, A., Van Riet, I., Fisher, L., Fernandez, P., Dewé, W., de Leval, J., & Castronovo, V. (January 1998). Expression of bone sialoprotein in human prostate cancer is associated with progression. Acta Clinica Belgica, 53 (3), 221-240.

Bellahcene, A., Maloujahmoum, N., Fisher, L. W., Pastorino, H., Tagliabue, E., Menard, S., & Castronovo, V. (September 1997). Expression of Bone Sialoprotein in Human Lung Cancer. Calcified Tissue International, 61 (3), 183-8. doi:10.1007/s002239900320

van den Brûle, F., Fernandez, P. L., Buicu, C., Liu, F.-T., Jackers, P., Lambotte, R., & Castronovo, V. (August 1997). Differential expression of galectin-1 and galectin-3 during first trimester human embryogenesis. Developmental Dynamics, 209 (4), 399-405. doi:10.1002/(SICI)1097-0177(199708)209:4<399::AID-AJA7>3.0.CO;2-D

Clausse, N., Jackers, P., & Castronovo, V. (June 1997). The 37 LRP/P40 polypeptide: a multifunctional pleiotropic molecule involved in tumorigenesis and metastasis - A review. Belgian Journal of Zoology, 127 (issue 1), 3-11.

al-Saleh, W., Delvenne, P., van den Brule, F. A., Menard, S., Boniver, J., & Castronovo, V. (March 1997). Expression of the 67 Kd Laminin Receptor in Human Cervical Preneoplastic and Neoplastic Squamous Epithelial Lesions: An Immunohistochemical Study. Journal of Pathology, 181 (3), 287-93. doi:10.1002/(SICI)1096-9896(199703)181:3<287::AID-PATH762>3.0.CO;2-W

Waltregny, D., de Leval, L., Ménard, S., de Leval, J., & Castronovo, V. (17 January 1997). Independent value of the 67-kilodalton laminin receptor in human prostate cancer [Paper presentation]. 4th Euregional Oncology meeting, Maastricht, Netherlands.

Ardini, E., Tagliabue, E., Magnifico, A., Buto, S., Castronovo, V., Colnaghi, M. I., & Menard, S. (1997). Co-regulation and physical association of the 67-kDa monomeric laminin receptor and the alpha6beta4 integrin. Journal of Biological Chemistry, 272 (4), 2342-5. doi:10.1074/jbc.272.4.2342

Bellahcene, A., & Castronovo, V. (January 1997). Expression of Bone Matrix Proteins in Human Breast Cancer: Potential Roles in Microcalcification Formation and in the Genesis of Bone Metastases. Bulletin du Cancer, 84 (1), 17-24.

Dehan, P., Waltregny, D., Beschin, A., Noël, A., Castronovo, V., Tryggvason, K., De Leval, J., & Foidart, J.-M. (1997). Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas. American Journal of Pathology, 151 (4), 1097-104.

Fernandez, P. L., Merino, M. J., Gomez, M., Campo, E., Medina, T., Castronovo, V., Sanjuan, X., Cardesa, A., Liu, F. T., & Sobel, M. E. (1997). Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. Journal of Pathology, 181 (1), 80-6. doi:10.1002/(SICI)1096-9896(199701)181:1<80::AID-PATH699>3.0.CO;2-E

Fontanini, G., Vignati, S., Chine, S., Lucchi, M., Mussi, A., Angeletti, C. A., Menard, S., Castronovo, V., & Bevilacqua, G. (1997). 67-kD laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas. Clinical Cancer Research, 3 (2), 227-31.

Maquoi, E., van den Brule, F. A., Castronovo, V., & Foidart, J.-M. (1997). Changes in the Distribution Pattern of Galectin-1 and Galectin-3 in Human Placenta Correlates with the Differentiation Pathways of Trophoblasts. Placenta, 18 (5-6, Jul-Aug), 433-9. doi:10.1016/S0143-4004(97)80044-6

Menard, S., Castronovo, V., Tagliabue, E., & Sobel, M. E. (1997). New insights into the metastasis-associated 67 kD laminin receptor. Journal of Cellular Biochemistry, 67 (2), 155-65. doi:10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.0.CO;2-W

Sanjuan, X., Fernandez, P. L., Castells, A., Castronovo, V., van den Brule, F., Liu, F. T., Cardesa, A., & Campo, E. (1997). Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology, 113 (6), 1906-15. doi:10.1016/S0016-5085(97)70010-6

van den Brûle, F., Bellahcene, A., Jackers, P., Liu, F.-T., Sobel, M. E., & Castronovo, V. (1997). Antisense galectin-3 alters thymidine incorporation in human MDA-MB435 breast cancer cells. International Journal of Oncology, 11 (2), 261-264. doi:10.3892/ijo.11.2.261

Viacava, P., Naccarato, A. G., Collecchi, P., Menard, S., Castronovo, V., & Bevilacqua, G. (1997). The spectrum of 67-kD laminin receptor expression in breast carcinoma progression. Journal of Pathology, 182 (1), 36-44. doi:10.1002/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W

Waltregny, D., de Leval, L., Ménard, S., de Leval, J., & Castronovo, V. (1997). Overexpression of the 67-kD laminin receptor correlates with tumor progression in human prostate cancer. Proceedings of the American Association for Cancer Research, 38, 429.

Waltregny, D., de Leval, L., Ménard, S., de Leval, J., & Castronovo, V. (1997). Independent value of the 67-kilodalton laminin receptor in human prostate cancer. Acta Clinica Belgica, 52 (2), 93.

Waltregny, D., de Leval, L., Menard, S., de Leval, J., & Castronovo, V. (1997). Independent prognostic value of the 67-kd laminin receptor in human prostate cancer. Journal of the National Cancer Institute, 89 (16), 1224-7. doi:10.1093/jnci/89.16.1224

Waltregny, D., de Leval, L., Ménard, S., de Leval, J., & Castronovo, V. (1997). Independent prognostic value of the 67-kD laminin receptor in human prostate cancer. British Journal of Urology, 80 (Suppl. 2), 231.

Charlier, C., Bruyneel, E., Lechanteur, C., Bracke, M., Mareel, M., & Castronovo, V. (19 December 1996). Enhancement of Tamoxifen-Induced E-Cadherin Function by Ca2+ Channel Antagonists in Human Breast Cancer Mcf7/6 Cells. European Journal of Pharmacology, 317 (2-3), 413-6. doi:10.1016/S0014-2999(96)00816-3

Clausse, N., Jackers, P., Jares, P., Joris, B., Sobel, M. E., & Castronovo, V. (15 December 1996). Identification of the active gene coding for the metastasis-associated 37LRP/p40 multifunctional protein. DNA and Cell Biology, 15 (12), 1009-23. doi:10.1089/dna.1996.15.1009

Castronovo, V., & Belotti, D. (December 1996). Tnp-470 (Agm-1470): Mechanisms of Action and Early Clinical Development. European Journal of Cancer, 32A (14), 2520-7. doi:10.1016/S0959-8049(96)00388-7

van den Brule, F. A., Buicu, C., Berchuck, A., Bast, R. C., Deprez, M., Liu, F. T., Cooper, D. N., Pieters, C., Sobel, M. E., & Castronovo, V. (November 1996). Expression of the 67-Kd Laminin Receptor, Galectin-1, and Galectin-3 in Advanced Human Uterine Adenocarcinoma. Human Pathology, 27 (11), 1185-91. doi:10.1016/S0046-8177(96)90313-5

Bellahcene, A., Menard, S., Bufalino, R., Moreau, L., & Castronovo, V. (22 August 1996). Expression of Bone Sialoprotein in Primary Human Breast Cancer Is Associated with Poor Survival. International Journal of Cancer, 69 (4), 350-3. doi:10.1002/(SICI)1097-0215(19960822)69:4<350::AID-IJC19>3.0.CO;2-9

Bellahcene, A., Antoine, N., Clausse, N., Tagliabue, E., Fisher, L. W., Kerr, J. M., Jares, P., & Castronovo, V. (August 1996). Detection of Bone Sialoprotein in Human Breast Cancer Tissue and Cell Lines at Both Protein and Messenger Ribonucleic Acid Levels. Laboratory Investigation, 75 (2), 203-10.

Jackers, P., Minoletti, F., Belotti, D., Clausse, N., Sozzi, G., Sobel, M. E., & Castronovo, V. (01 August 1996). Isolation from a multigene family of the active human gene of the metastasis-associated multifunctional protein 37LRP/p40 at chromosome 3p21.3. Oncogene, 13 (3), 495-503.

van den Brule, F. A., Castronovo, V., Menard, S., Giavazzi, R., Marzola, M., Belotti, D., & Taraboletti, G. (August 1996). Expression of the 67 Kd Laminin Receptor in Human Ovarian Carcinomas as Defined by a Monoclonal Antibody, Mluc5. European Journal of Cancer, 32A (9), 1598-602. doi:10.1016/0959-8049(96)00119-0

Chariot, A., & Castronovo, V. (11 May 1996). Detection of Hoxa1 Expression in Human Breast Cancer. Biochemical and Biophysical Research Communications, 222 (2), 292-7. doi:10.1006/bbrc.1996.0737

Bellahcene, A., Kroll, M., Liebens, F., & Castronovo, V. (May 1996). Bone Sialoprotein Expression in Primary Human Breast Cancer Is Associated with Bone Metastases Development. Journal of Bone and Mineral Research, 11 (5), 665-70. doi:10.1002/jbmr.5650110514

Castronovo, V., van den Brule, F., Jackers, P., Clausse, N., Liu, F.-T., Gillet, C., & Sobel, M. E. (May 1996). Decreased expression of galectin-3 is associated with progression of human breast cancer. Journal of Pathology, 179 (1), 43-48. doi:10.1002/(SICI)1096-9896(199605)179:1<43::AID-PATH541>3.0.CO;2-N

Waltregny, D., de Leval, L., Ménard, S., de Leval, J., & Castronovo, V. (March 1996). Overexpression of the 67-kDa laminin receptor correlates with tumor progression in human prostate cancer. Clinical and Experimental Metastasis, 14 (Suppl. 1), 1996.

Jackers, P., Clausse, N., Fernandez, M.-T., Berti, A., Princen, F., Wewer, U., Sobel, M. E., & Castronovo, V. (07 February 1996). Seventeen copies of the human 37 kDa laminin receptor precursor/p40 ribosome-associated protein gene are processed pseudogenes arisen from retropositional events. Biochimica et Biophysica Acta, 1305 (1-2), 98-104. doi:10.1016/0167-4781(95)00206-5

Antoine, N., Daukandt, M., Heinen, E., Simar, L. J., & Castronovo, V. (February 1996). In Vitro and in Vivo Stimulation of the Murine Immune System by Agm-1470, a Potent Angiogenesis Inhibitor. American Journal of Pathology, 148 (2), 393-8.

Antoine, N., Daukandt, M., Locigno, R., Heinen, E., Simar, L. J., & Castronovo, V. (1996). The Potent Angioinhibin Agm-1470 Stimulates Normal but Not Human Tumoral Lymphocytes. Tumori Journal, 82 (1, Jan-Feb), 27-30. doi:10.1177/030089169608200105

Basolo, F., Pollina, L., Pacini, F., Fontanini, G., Menard, S., Castronovo, V., & Bevilacqua, G. (1996). Expression of the Mr 67,000 laminin receptor is an adverse prognostic indicator in human thyroid cancer: an immunohistochemical study. Clinical Cancer Research, 2 (10), 1777-80.

Bracke, M., Van Roy, F., Castronovo, V., & Mareel, M. (1996). Tamoxifen and the E-Cadherin/Catenin complex. In In The Enigma of Tamoxifen (pp. 267-284). John A. Kellen (Eds).

Chariot, A., Castronovo, V., Le, P., Gillet, C., Sobel, M. E., & Gielen, J. (1996). Cloning and expression of a new HOXC6 transcript encoding a repressing protein. Biochemical Journal, 319, 91-97. doi:10.1042/bj3190091

Clausse, N., Jackers, P., Jarès, P., & Castronovo, V. (1996). High conservation of the 37 kDa laminin receptor precursor/p40 ribosomal associated protein between mammals and birds: characterization of the chicken gene and cDNA. Cell Biology International, 20, 314-315.

Gollogly, L., & Castronovo, V. (1996). A Possible Role for the Alpha 1-->3 Galactosyl Epitope and the Natural Anti-Gal Antibody in Oncogenesis. Neoplasma, 43 (5), 285-9.

Jackers, P., Minoletti, F., Belotti, D., Clausse, N., Sozzi, G., & Castronovo, V. (1996). The human 37kDa laminin receptor precursor/p40 ribosomal associated protein multigene family : structure of the active gene and chromosomal location at 3p21.3. Cell Biology International, 20, 316-317.

Karpatova, M., Tagliabue, E., Castronovo, V., Magnifico, A., Ardini, E., Morelli, D., Belotti, D., Colnaghi, M. I., & Menard, S. (1996). Shedding of the 67-kD laminin receptor by human cancer cells. Journal of Cellular Biochemistry, 60 (2), 226-34. doi:10.1002/(SICI)1097-4644(19960201)60:2<226::AID-JCB7>3.0.CO;2-Z

Magnifico, A., Tagliabue, E., Buto, S., Ardini, E., Castronovo, V., Colnaghi, M. I., & Menard, S. (1996). Peptide G, containing the binding site of the 67-kDa laminin receptor, increases and stabilizes laminin binding to cancer cells. Journal of Biological Chemistry, 271 (49), 31179-84. doi:10.1074/jbc.271.49.31179

Sanjuan, X., Fernandez, P. L., Miquel, R., Munoz, J., Castronovo, V., Menard, S., Palacin, A., Cardesa, A., & Campo, E. (1996). Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma. Journal of Pathology, 179 (4), 376-80. doi:10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V

Waltregny, D., & Castronovo, V. (1996). Recent advances in prostate cancer metastasis. Tumori Journal, 82 (3, May-Jun), 193-204.

Dejardin, E., Bonizzi, G., Bellahcene, A., Castronovo, V., Merville, M.-P., & Bours, V. (02 November 1995). Highly-Expressed P100/P52 (Nfkb2) Sequesters Other Nf-Kappa B-Related Proteins in the Cytoplasm of Human Breast Cancer Cells. Oncogene, 11 (9), 1835-41.

Chariot, A., Moreau, L., Senterre, G., Sobel, M. E., & Castronovo, V. (13 October 1995). Retinoic Acid Induces Three Newly Cloned Hoxa1 Transcripts in Mcf7 Breast Cancer Cells. Biochemical and Biophysical Research Communications, 215 (2), 713-20. doi:10.1006/bbrc.1995.2522

van den Brule, F. A., Buicu, C., Baldet, M., Sobel, M. E., Cooper, D. N., Marschal, P., & Castronovo, V. (17 April 1995). Galectin-1 Modulates Human Melanoma Cell Adhesion to Laminin. Biochemical and Biophysical Research Communications, 209 (2), 760-7. doi:10.1006/bbrc.1995.1564

Antoine, N., Bours, V., Heinen, E., Simar, L. J., & Castronovo, V. (18 January 1995). Simulation of Human B-Lymphocyte Proliferation by Agm-1470, a Potent Inhibitor of Angiogenesis. Journal of the National Cancer Institute, 87 (2), 136-9. doi:10.1093/jnci/87.2.136

Bellahcene, A., & Castronovo, V. (January 1995). Increased Expression of Osteonectin and Osteopontin, Two Bone Matrix Proteins, in Human Breast Cancer. American Journal of Pathology, 146 (1), 95-100.

Carbone, A., Gloghini, A., Colombatti, A., Castronovo, V., & Menard, S. (1995). Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistry. Human Pathology, 26 (5), 541-6. doi:10.1016/0046-8177(95)90251-1

Charlier, C., Chariot, A., Antoine, N., Merville, M.-P., Gielen, J., & Castronovo, V. (January 1995). Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochemical Pharmacology, 49, 351-358. doi:10.1016/0006-2952(94)00492-5

van den Brule, F. A., Buicu, C., Sobel, M. E., Liu, F. T., & Castronovo, V. (1995). Galectin-3, a Laminin Binding Protein, Fails to Modulate Adhesion of Human Melanoma Cells to Laminin. Neoplasma, 42 (5), 215-9.

van den Brule, F. A., Lambotte, R., & Castronovo, V. (1995). Cancers épithéliaux de l'ovaire. Acquisitions récentes. Journal de Gynécologie, Obstétrique et Biologie de la Reproduction, 24 (3), 241-52.

Gorski, A., Castronovo, V., Stepien-Sopniewska, B., Grieb, P., Ryba, M., Mrowiec, T., Korczak-Kowalska, G., Wierzbicki, P., Matysiak, W., & Dybowska, B. (July 1994). Depressed Immune Surveillance against Cancer: Role of Deficient T Cell: Extracellular Matrix Interactions. Cell Adhesion and Communication, 2 (3), 225-33. doi:10.3109/15419069409004441

Bellahcene, A., Merville, M.-P., & Castronovo, V. (01 June 1994). Expression of Bone Sialoprotein, a Bone Matrix Protein, in Human Breast Cancer. Cancer Research, 54 (11), 2823-6.

van den Brule, F. A., Price, J., Sobel, M. E., Lambotte, R., & Castronovo, V. (11 May 1994). Inverse Expression of Two Laminin Binding Proteins, 67lr and Galectin-3, Correlates with the Invasive Phenotype of Trophoblastic Tissue. Biochemical and Biophysical Research Communications, 201 (1), 388-93. doi:10.1006/bbrc.1994.1713

Bellahcene, A., Merville, M.-P., Gielen Jacques, Lambotte, R., Simar, L., & Castronovo, V. (01 May 1994). La protéine P53, protectrice de l'intégrité du génome: rôle dans la genèse des cancers. Revue Médicale de Liège, 49 (5), 274-84.

Antoine, N., Greimers, R., De Roanne, C., Kusaka, M., Heinen, E., Simar, L. J., & Castronovo, V. (15 April 1994). Agm-1470, a Potent Angiogenesis Inhibitor, Prevents the Entry of Normal but Not Transformed Endothelial Cells into the G1 Phase of the Cell Cycle. Cancer Research, 54 (8), 2073-6.

Bours, V., Dejardin, E., Goujon-Letawe, F., Merville, M.-P., & Castronovo, V. (13 January 1994). The Nf-Kappa B Transcription Factor and Cancer: High Expression of Nf-Kappa B- and I Kappa B-Related Proteins in Tumor Cell Lines. Biochemical Pharmacology, 47 (1), 145-9. doi:10.1016/0006-2952(94)90448-0

Castronovo, V., Kusaka, M., Chariot, A., Gielen, J.-L., & Sobel, M. (13 January 1994). Homeobox Genes: Potential Candidates for the Transcriptional Control of the Transformed and Invasive Phenotype. Biochemical Pharmacology, 47 (1), 137-43. doi:10.1016/0006-2952(94)90447-2

Barondes, S. H., Castronovo, V., Cooper, D. N., Cummings, R. D., Drickamer, K., Feizi, T., Gitt, M. A., Hirabayashi, J., Hughes, C., & Kasai, K. (1994). Galectins: a family of animal beta-galactoside-binding lectins. Cell, 76 (4), 597-8. doi:10.1016/0092-8674(94)90498-7

Bracke, M. E., Charlier, C., Bruyneel, E. A., Labit, C., Mareel, M. M., & Castronovo, V. (1994). Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Research, 54, 4607-4609.

Bracke, M., Charlier, C., Bruyneel, E., Mareel, M., & Castronovo, V. (1994). Tamoxifen activates the cell-cell adhesion function of E-Cadherin in MCF-7/6 human mammary carcinoma cells [Poster presentation]. Proceedings of American Association for Cancer Research eighty fifth annual meeting.

Charlier, C., Colin, C., Merville, M.-P., Lambotte, R., Plomteux, G., Castronovo, V., & Gielen, J. (1994). Le tamoxifene dans le traitement du cancer du sein. Journal de Gynécologie, Obstétrique et Biologie de la Reproduction, 23 (7), 751-6.

Romanov, V., Sobel, M. E., pinto da Silva, P., Menard, S., & Castronovo, V. (1994). Cell localization and redistribution of the 67 kD laminin receptor and alpha 6 beta 1 integrin subunits in response to laminin stimulation: an immunogold electron microscopy study. Cell Adhesion and Communication, 2 (3), 201-9. doi:10.3109/15419069409004438

van den Brule, F. A., Berchuck, A., Bast, R. C., Liu, F. T., Gillet, C., Sobel, M. E., & Castronovo, V. (1994). Differential Expression of the 67-Kd Laminin Receptor and 31-Kd Human Laminin-Binding Protein in Human Ovarian Carcinomas. European Journal of Cancer, 30A (8), 1096-9. doi:10.1016/0959-8049(94)90464-2

van den Brûle, F., Jackers, P., & Castronovo, V. (1993). Adhesion of cancer cells to laminin: a critical event of tumor invasion and metastasis. In Vèmes Journées Liégeoises de Gynécologie - Obstétrique (pp. 9 - 32).

van den Brûle, F., Jackers, P., & Castronovo, V. (1993). Adhesion of cancer cells to laminin: a critical event of tumor invasion and metastasis [Paper presentation]. Vème Journées Liégeoises de Gynecologie - obstétrique, Liège, Belgium.

Castronovo, V. (1993). Laminin Receptors and Laminin-Binding Proteins During Tumor Invasion and Metastasis. Invasion and Metastasis, 13 (1), 1-30.

Cioce, V., Margulies, I. M., Sobel, M. E., & Castronovo, V. (1993). Interaction between the 67 kilodalton metastasis-associated laminin receptor and laminin. Kidney International, 43 (1), 30-7. doi:10.1038/ki.1993.7

Lauricella-Lefebvre, M. A., Castronovo, V., Sato, H., Seiki, M., French, D. L., & Merville, M.-P. (1993). Stimulation of the 92-Kd Type Iv Collagenase Promoter and Enzyme Expression in Human Melanoma Cells. Invasion and Metastasis, 13 (6), 289-300.

Taraboletti, G., Belotti, D., Giavazzi, R., Sobel, M. E., & Castronovo, V. (1993). Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis. Journal of the National Cancer Institute, 85 (3), 235-40. doi:10.1093/jnci/85.3.235

Campo, E., Monteagudo, C., Castronovo, V., Claysmith, A. P., Fernandez, P. L., & Sobel, M. E. (1992). Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissues by in situ hybridization. American Journal of Pathology, 141 (5), 1073-83.

Castronovo, V. (1992). Interactions entre cellules cancéreuses et laminine au cours de l'invasion tumorale et de la dissémination métastatique [Post doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/63733

Castronovo, V., Campo, E., van den Brule, F. A., Claysmith, A. P., Cioce, V., Liu, F. T., Fernandez, P. L., & Sobel, M. E. (1992). Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma. Journal of the National Cancer Institute, 84 (15), 1161-9. doi:10.1093/jnci/84.15.1161

Castronovo, V., Luyten, F., van den Brule, F., & Sobel, M. E. (1992). Identification of a 14-kDa laminin binding protein (HLBP14) in human melanoma cells that is identical to the 14-kDa galactoside binding lectin. Archives of Biochemistry and Biophysics, 297 (1), 132-8. doi:10.1016/0003-9861(92)90650-L

Tennenbaum, T., Yuspa, S. H., Grover, A., Castronovo, V., Sobel, M. E., Yamada, Y., & De Luca, L. M. (1992). Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression. Cancer Research, 52 (10), 2966-76.

van den Brule, F. A., Engel, J., Stetler-Stevenson, W. G., Liu, F. T., Sobel, M. E., & Castronovo, V. (1992). Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells. International Journal of Cancer, 52 (4), 653-7. doi:10.1002/ijc.2910520426

Castronovo, V., Claysmith, A. P., Barker, K. T., Cioce, V., Krutzsch, H. C., & Sobel, M. E. (May 1991). Biosynthesis of the 67 kDa high affinity laminin receptor. Biochemical and Biophysical Research Communications, 177 (1), 177-83. doi:10.1016/0006-291X(91)91965-F

Castronovo, V., Bracke, M. E., Mareel, M. M., Reznik, M., & Foidart, J.-M. (March 1991). Absence of Laminin Deposition in Breast Cancer and Metastases except to the Brain. Pathology - Research and Practice, 187 (2-3), 201-8. doi:10.1016/S0344-0338(11)80772-7

Castronovo, V., Stetler-Stevenson, W. G., Sobel, M. E., & Liotta, L. A. (1991). Molecular inhibition of cancer cell invasion and metastasis. Princess Takamatsu Symposia, 22, 319-37.

Castronovo, V., Taraboletti, G., & Sobel, M. E. (1991). Laminin receptor complementary DNA-deduced synthetic peptide inhibits cancer cell attachment to endothelium. Cancer Research, 51 (20), 5672-8.

Castronovo, V., Taraboletti, G., & Sobel, M. E. (1991). Functional domains of the 67-kDa laminin receptor precursor. Journal of Biological Chemistry, 266 (30), 20440-6.

Cioce, V., Castronovo, V., Shmookler, B. M., Garbisa, S., Grigioni, W. F., Liotta, L. A., & Sobel, M. E. (1991). Increased expression of the laminin receptor in human colon cancer. Journal of the National Cancer Institute, 83 (1), 29-36. doi:10.1093/jnci/83.1.29

Coopman, P., Verhasselt, B., Bracke, M., De Bruyne, G., Castronovo, V., Sobel, M., Foidart, J.-M., Van Roy, F., & Mareel, M. (1991). Arrest of MCF-7 cell migration by laminin in vitro: possible mechanisms. Clinical and Experimental Metastasis, 9 (5), 469-84. doi:10.1007/BF01785532

D'Errico, A., Garbisa, S., Liotta, L. A., Castronovo, V., Stetler-Stevenson, W. G., & Grigioni, W. F. (1991). Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Modern Pathology, 4 (2), 239-46.

Fernandez, M. T., Castronovo, V., Rao, C. N., & Sobel, M. E. (1991). The high affinity murine laminin receptor is a member of a multicopy gene family. Biochemical and Biophysical Research Communications, 175 (1), 84-90. doi:10.1016/S0006-291X(05)81203-3

Lewalle, J. M., Castronovo, V., Goffinet, G., & Foidart, J.-M. (1991). Malignant cell attachment to endothelium of ex vivo perfused human umbilical vein. Modulation by platelets, plasma and fibronectin. Thrombosis Research, 62 (4), 287-98. doi:10.1016/0049-3848(91)90149-Q

Colin, C., Lifrange, E., Genicot, F., Castronovo, V., & Lambotte, R. (November 1990). Le tamoxifene comme premier traitement du cancer du sein chez la femme âgée: un recul de 10 ans. Revue Médicale de Liège, 45 (11), 533-8.

Basson, C. T., Knowles, W. J., Bell, L., Albelda, S. M., Castronovo, V., Liotta, L. A., & Madri, J. A. (1990). Spatiotemporal segregation of endothelial cell integrin and nonintegrin extracellular matrix-binding proteins during adhesion events. Journal of Cell Biology, 110 (3), 789-801. doi:10.1083/jcb.110.3.789

Castronovo, V., Colin, C., Claysmith, A. P., Chen, P. H., Lifrange, E., Lambotte, R., Krutzsch, H., Liotta, L. A., & Sobel, M. E. (1990). Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. American Journal of Pathology, 137 (6), 1373-81.

Castronovo, V., & Sobel, M. E. (1990). Laminin and fibronectin increase the steady state level of the 67 kD high affinity metastasis-associated laminin receptor mRNA in human cancer cells. Biochemical and Biophysical Research Communications, 168 (3), 1110-7. doi:10.1016/0006-291X(90)91144-H

Castronovo, V., Colin, C., Parent, B., Foidart, J.-M., Lambotte, R., & Mahieu, P. (01 February 1989). Possible Role of Human Natural Anti-Gal Antibodies in the Natural Antitumor Defense System. Journal of the National Cancer Institute, 81 (3), 212-6. doi:10.1093/jnci/81.3.212

Castronovo, V., Taraboletti, G., Liotta, L. A., & Sobel, M. E. (1989). Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. Journal of the National Cancer Institute, 81 (10), 781-8. doi:10.1093/jnci/81.10.781

Rahman, A., Panneerselvam, M., Guirguis, R., Castronovo, V., Sobel, M. E., Abraham, K., Daddona, P. E., & Liotta, L. A. (1989). Anti-laminin receptor antibody targeting of liposomes with encapsulated doxorubicin to human breast cancer cells in vitro. Journal of the National Cancer Institute, 81 (23), 1794-800. doi:10.1093/jnci/81.23.1794

Rao, C. N., Castronovo, V., Schmitt, M. C., Wewer, U. M., Claysmith, A. P., Liotta, L. A., & Sobel, M. E. (1989). Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. Biochemistry, 28 (18), 7476-86. doi:10.1021/bi00444a047

Vecchi, M. L., Davin, J. C., Castronovo, V., Foidart, J.-M., Malaise, M., Foidart, J. B., Dechene, C., Sangiorgi, G. B., & Mahieu, P. (1989). Reactivity of human anti-alpha-galactosyl IgG antibody with alpha(1-->3)-linked galactosyl epitopes exposed on basement membranes and on glomerular epithelial cells: an in vitro and in vivo study in the mouse. Clinical and Experimental Immunology, 78 (2), 271-7.

Bracke, M., Castronovo, V., De Bruyne, G., Coopman, P., Foidart, J.-M., & Mareel, M. (1988). Interactions of invasive cells with native and modified extracellular matrix in vitro. Advances in Experimental Medicine and Biology, 233, 171-8. doi:10.1007/978-1-4899-5037-6_19

Bracke, M. E., De Pestel, G., Castronovo, V., Vyncke, B., Foidart, J.-M., Vakaet, L. C., & Mareel, M. (1988). Flavonoids inhibit malignant tumor invasion in vitro. Progress in Clinical and Biological Research, 280, 219-33.

Castronovo, V., Parent, B., Foidart, J.-M., Heynen, E., Goffinet, G., Lambotte, R., & Mahieu, P. (1988). Perfusion of Human Umbilical Veins. A New Approach to Study the Interactions of Circulating Malignant Cells with Vascular Wall and Their Modulations. Invasion and Metastasis, 8 (6), 332-50.

Bracke, M. E., Castronovo, V., Van Cauwenberge, R. M., Coopman, P., Vakaet, L. J., Strojny, P., Foidart, J.-M., & Mareel, M. M. (November 1987). The anti-invasive flavonoid (+)-catechin binds to laminin and abrogates the effect of laminin on cell morphology and adhesion. Experimental Cell Research, 173 (1), 193-205. doi:10.1016/0014-4827(87)90345-4

Castronovo, V. (1987). Contribution à l’étude du rôle de la laminine et des résidus alpha-galactosyl dans l’invasion tumorale et la dissémination métastatique [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/63639

Castronovo, V., Foidart, J.-M., Li Vecchi, M., Foidart, J. B., Bracke, M., Mareel, M., & Mahieu, P. (1987). Human Anti-Alpha-Galactosyl Igg Reduces the Lung Colonization by Murine Mo4 Cells. Invasion and Metastasis, 7 (6), 325-45.

Emonard, H., Calle, A., Grimaud, J. A., Peyrol, S., Castronovo, V., Noël, A., Lapière, C., Kleinman, H. K., & Foidart, J.-M. (1987). Interactions between fibroblasts and a reconstituted basement membrane matrix. Journal of Investigative Dermatology, 89, 156-163. doi:10.1111/1523-1747.ep12470552

Bracke, M. E., Van Cauwenberge, J.-R., Mareel, M. M., Castronovo, V., & Foidart, J.-M. (1986). Flavonoids : tools for the study of tumor invasion in vitro. In Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological and Structure-Activity Relationships (pp. 441-444). New York, United States: In Middleton E. Jr, Alan R. Liss Inc.

Castronovo, V., Bracke, M., Mareel, M., & Foidart, J.-M. (1985). An accumulation of laminin precedes invasion by transformed MO4 cells. In Biology and Chemistry of Basement Membranes (pp. 447-448). Amsterdam, Netherlands: In Shibata S., Elsevier Sciences.

Castronovo, V., & Foidart, J.-M. (1985). Interaction between human breast adenocarcinoma cells and type I collagen matrix requires fibronectin. In Biology and Chemistry of Basement Membranes (pp. 445-446). Amsterdam, Netherlands: In Shibata S., Elsevier Sciences.

Castronovo, V., Paye, M., Courtois, R., & Foidart, J.-M. (1985). Fibronectin mediates the retraction of type I collagen fibers by breast cancer cells. In Evaluation du Risque de Cancer Mammaire. Chimiothérapie Première ? (pp. 249-258). Liège, Bruxelles, Belgium: In Colin C., Gordenne W. - Pierre Mardaga.

Foidart, J.-M., Verly, M., Castronovo, V., Van Cawenberge, J. R., Colin, C., Mahieu, P., Kinet, J. P., Timpl, R., Lapière, C., Nusgens, B., Pierard, D., & Birembaut, P. H. (1985). Interactions of human breast adenocarcinoma with the extracellular matrix - a new concept to study cancer invasion. In Evaluation du Risque de Cancer Mammaire. Chimiothérapie Première ? (pp. 225-238). Liège, Bruxelles, Belgium: In Colin C., Gordenne W. - Pierre Mardaga.

FOCAN, C., Castronovo, V., COLETTE, J., FOCAN-HENRARD, D., FRERE, M. H., LE HUNG, S., TOUITOU, Y., FRANCHIMONT, P., IN REINBERG, A., SMOLENSKY, M., & LABRECQUE, G. (1984). Circadian variation in serum concentration of carcinoembryonic antigen (CEA) is altered in cancer patients. In Annual Review of Chronopharmacology - Vol 1 (pp. 111-114). PERGAMON PRESS.

Focan, C., Castronovo, V., Colette, J., Focan-Henrard, D., Frere, M. H., Le Hung, S., Touitou, Y., Levi, F., Hrushesky, W., & Franchimont, P. (1984). Alteration of circadian variation in serum concentrations of carcino-embryonic antigen (CEA) in cancer. In Protides of the Biological Fluids (pp. 703-705). In Peeters H., Pergamon Press.

Castronovo, V., Stetler-Stevenson, W. G., Sobel, M. E., & Liotta, L. A. (1982). Molecular Inhibition of tumor invasion and metastasis. In Proceedings of the 22nd Princess Takamatsu Symposia 1991 CRC Press (pp. 319-338). C. Harris and al.

Castronovo, V., Simar, L., & Geubelle, F. (15 October 1981). Infections respiratoires et pathologie de la clairance muco-ciliaire. Revue Médicale de Liège, 36 (20), 760-6.